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Summary 
Staphylococcus epidermidis is the most common cause of device-associated infections 
among CoNS. It was shown that surface proteins have important roles for attaching and 
connecting the bacterial cells to the surface of medical devices. Investigation of the most 
effective antibody against surface proteins in the biofilm formed by S. epidermidis, led to 
the SesC protein as the best candidate. 
The purposes of this project were to find the function of this surface protein in biofilm 
formation by these bacteria and also using the protein as a potential vaccine target. 
To explain the role of SesC in the biofilm, first we tried to find a sesC natural mutant in 
S. epidermidis. Our investigation suggests that sesC is a conserved gene in this bacterial 
species and specifically present in S. epidermidis, not other staphylococci. 
Since our efforts to knock out sesC were unsuccessful, we used an alternative strategy, 
which consisted in transforming another staphylococcus, S. aureus, with sesC and 
investigating the resulting changes in biofilm formation. We showed that a PIA-
dependent strain transformed with and expressing SesC switched to a protein-dependent 
biofilm formation. This suggests that SesC has an important role in connecting the cells 
to each other or even to the surface.  
Using the antibody against SesC on the biofilm of the transformant strain with sesC, in 
vivo results suggest that SesC can be a good candidate for vaccine development. 
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Samenvatting 
	
Staphylococcus epidermis is de meest voorkomende oorzaak van biomateriaal-
geassocieerde infecties (lijninfecties of katheterinfecties) onder Coagulase-Negatieve 
Stafylokokken (CoNS). Het is aangetoond dat oppervlakte-eiwitten een belangrijke rol 
spelen bij het aanhechten van bacteriële cellen aan het oppervlak van medische 
hulpmiddelen. Uit onderzoek naar het meest effectieve antilichaam tegen oppervlakte-
eiwitten in de biofilm gevormd door S. epidermidis, kwam het eiwit SesC naar voren als 
beste kandidaat eiwit.  
De doelen van dit project waren enerzijds het achterhalen van de functie van dit eiwit in 
de biofilmvorming van deze bacteriën en anderzijds onderzoeken of dit eiwit gebruikt 
kon worden als een potentieel doelwit voor vaccinatie.  
Om de rol van SesC in biofilmvorming te achterhalen, probeerden we eerst om een 
natuurlijk voorkomende mutant van het eiwit te vinden in S. epidermis. Ons onderzoek 
suggereert dat sesC een geconserveerd gen is in deze bacteriële soort dat specifiek 
aanwezig in S. epidermidis, maar niet in andere stafylokokken.  
Aangezien onze inspanningen om een knockout van het sesC-gen te bekomen, niet 
succesvol waren, gebruikten we een andere strategie die eruit bestond om een andere 
stafylokokken- soort, S. aureus, te transformeren met sesC en vervolgens de 
veranderingen in biofilmvorming te bestuderen. We hebben aangetoond dat een PIA-
afhankelijke stam die getransformeerd werd met sesC en het eiwit tot expressie bracht, 
overschakelde naar een eiwitafhankelijke biofilmvorming. Dit suggereert dat SesC een 
belangrijke rol speelt bij de verbinding van bacteriële cellen met elkaar en met het 
oppervlak.  
De in vivo resultaten van het gebruik van het antilichaam tegen SesC tegen de biofilm van 
de met sesC-getransformeerde stam, suggereren dat SesC een goede kandidaat is voor de 
ontwikkeling van een vaccin. 
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 Microbiological profile of staphylococci 1.1
Staphylococci belong to the Staphylococcaceae family, and the genus 
Staphylococcus includes at least 47 species (Becker et al. 2014). These Gram-positive 
spherical bacteria appear in pairs or grape-like clusters (Figure 1.1) and most species 
are currently considered as important human opportunistic pathogens (Deighton et al. 
1992; Trülzsch et al. 2007). 
  
Figure 1.1. Scanning electron microscopy of Staphylococcus epidermidis clusters embedded in 
exopolymeric substance (http://staphylococcusepidermidis.org). 
 
The Staphylococcus genus is divided into two large groups based on the ability to 
produce the enzyme coagulase as observed by the clotting of plasma. The absence of 
this enzyme is the key characteristic of coagulase-negative staphylococci (CoNS), 
differentiating them from coagulase-positive staphylococci, mainly Staphylococcus 
aureus. Staphylococcus epidermidis is the most frequently isolated member of CoNS 
(Götz, Bannerman, & Schleifer, 2006). 
Other characteristics, such as colony morphology, pigmentation, and hemolysis vary 
among CoNS. Phenotypic variation is frequently found among these bacteria (Handke 
et al., 2004), and this may be due to the high level of DNA sequence diversity, even 
within a single species (Miragaia et al. 2007). 
 Pathogenesis of infections by coagulase-negative staphylococci  1.2
CoNS have been accepted as the major opportunistic pathogens on the surface of the 
human body (Becker et al. 2014). Many human infections are associated with CoNS, 
such as meningitis, pneumonia, enterocolitis, otitis media, urinary tract infections, 
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surgical wound infections, and a series of medical device-related infections. Medical 
implants prone to infections include prosthetic heart valves, intravascular catheters, 
vascular grafts, cardiac pacemakers, intraocular lenses, breast implants, genitourinary 
prostheses, prosthetic joints, hemodialysis shunts and grafts, central nervous system 
shunts, and many other surgically inserted appliances (Cervera et al. 2009; Von Eiff et 
al. 2005; Guggenbichler et al. 2011). 
Among all CoNS, S. epidermidis has the highest clinical importance. Although S. 
epidermidis had long been considered as a non-pathogenic species, it has gradually 
been recognized as a relevant opportunistic pathogen for the following reasons:  
- 65-90% of all Staphylococcus spp. recovered from human infections are S. 
epidermidis (de Allori et al. 2006).  
- S. epidermidis bloodstream infections are particularly problematic in 
neonates and it has been recognized as the most common cause of neonatal 
morbidity and mortality (Cheung & Otto 2010). 
- S. epidermidis often becomes the major infective agent in compromised 
patients, such as immuno-compromised patients under immuno-suppressive 
therapy, AIDS patients and drug abuse patients. In all of these infections, the 
port of entry into the human body is usually an intravascular catheter 
(Domingo & Fontanet 2001; Tacconelli et al. 1997). 
- Together with S. aureus, S. epidermidis is the major cause of surgical site 
infections (Foster 1996). 
- S. epidermidis ability to establish multilayered, highly structured clusters on 
artificial surfaces makes it a frequent cause of native valve endocarditis 
(NVE), and infections related to orthopedic prostheses and vascular catheters 
(Chu et al. 2008).  
 Staphylococci and medical device-related infections 1.3
Modern medicine increasingly requires the use of indwelling medical devices to 
prolong and improve the quality of life for many individuals. However, the frequent use 
of these devices is associated with side effects as they may become contaminated with 
bacteria, which adhere to the surface thereby acting as a source of infection. The 
potential sources of catheter-related infection (CRI) are contiguous skin flora, 
contamination of the catheter hub and lumen, contamination of infusion fluid, and 
hematogenous colonization of the intravascular device (IVD) from distant, unrelated 
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sites of infection (Figure 1.2) (Crnich & Maki 2002; Dunne & Dunne 2002). The 
majority of infections caused by S. epidermidis are acquired in hospitals and are 
associated with the use of medical devices such as the catheters (Figure 1.2) (Conen et 
al. 2008). This ability to cause infection is due to adhesion of S. epidermidis strains to 
the device surface which permits multicellular agglomeration with a characteristic 
three-dimensional structure and physiology which is called “biofilm” (Cherifi et al. 
2013).	
 
 
 
 Figure 1.2. Potential sources of bloodstream infections related to the catheter. The 
contiguous skin flora, contaminated catheter hub and lumen, contaminated infusate, 
hematogenous colonization of the device from distant infections and contamination of devices 
prior to insertion are the most common cause of CRI (Crnich & Maki, 2002). 
 
S. epidermidis can cause different infections by spreading and forming biofilms in the 
body. By attaching to non-biological and biological surfaces and forming biofilms in a 
self-produced matrix, these bacteria promote their survival and stability in natural 
environments (Hall-Stoodley et al. 2004). Bacteria on the skin or in the oral cavity can 
transiently enter the bloodstream and colonize. The irregular detachment of biofilms 
leads to cycles of bacteremia (Figure 1.3).      
Staphylococcal biofilm can additionally be facilitated by the host inflammatory 
response since host inflammatory molecules promote adhesion to the surface of a 
device (Hall-Stoodley et al. 2004; Cherifi et al. 2013). 
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Figure1.3. Schematic showing the 
examples of possible infectious points of 
entry of S. epidermidis into the body; 
catheter, hip replacement, and periodontal 
disease (Hall-Stoodley et al. 2004).  
 
 
 
 
 
 
 
 Development of staphylococcal biofilms 1.4
Essentially, biofilms are complex microbial communities in which bacteria get 
different characteristics from their planktonic counterparts, such as elevated resistance 
to antibiotics and host defenses. “Therefore, a biofilm can be defined as a community of 
bacteria that is notoriously resistant to immune system attack and antimicrobial agents” 
(Høiby et al. 2010).  
The complexity of biofilm structure and development, and its importance in both 
natural and man-made environments, has been recognized and investigated over the 
past years and this could help to identify the molecular mechanisms that are involved in 
biofilm development (Hall-Stoodley et al. 2004).  
The development of a biofilm occurs in several steps. It starts with the initial adhesion 
of cells to a surface and their subsequent accumulation, followed by the maturation 
phase, and finally the detachment of cells or cell clusters from the formed biofilm, 
which may lead to the dissemination of an infection (Figure 1.4) (Otto 2009). 
 
 
CHAPTER	I:	General	Introduction	
	 6	
 
Figure 1.4. Schematic overview of the different stages of staphylococcal biofilm formation.  
Attachment to uncoated material is mainly related to cell surface hydrophobicity, while 
dedicated surface proteins mediate adhesion to host matrix-covered devices. 
Exopolysaccharide, specific proteins, and accessory macromolecules provide intercellular 
aggregation. Mechanisms of biofilm maturation, detachment, and structuring are poorly 
understood, but possibly involve quorum-sensing controlled expression of peptides and 
proteolytic activity in exposed layers of the biofilm. Genome-wide gene expression is 
significantly different in the biofilm compared to the planktonic mode of growth and includes 
down-regulation of cell processes (adapted from Otto 2009). 
 
1.4.1  Initial attachment 
Direct interaction of a medical device with bacterial cells occurs via non-specific 
physicochemical forces such as polarity, van der Waal’s forces and hydrophobic 
interactions. Before initial bacterial cell attachment, however, “surface conditioning” 
often is needed where a surface becomes first coated with adsorbed bridging molecules 
(Lindsay & von Holy 2006). After insertion, the implanted material rapidly becomes 
coated with plasma and extracellular matrix proteins such as fibrinogen (Fg), 
fibronectin (Fn), vitronectin (Vn), thrombospondin and von Willebrand factor (Devine 
2003). 
Some surface components in bacteria adhere to factors involved in the “conditioning 
film” and assist to the initial attachment of cells. For example, in S. epidermidis, 
microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) 
harbor binding sites for human matrix proteins such as fibronectin, collagen, laminin, 
vitronectin, elastin, and fibrinogen. Staphylococcal MSCRAMMs can attach either 
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directly or indirectly (Figure 1.5). In S. epidermidis, autolysin E (AtlE) is a protein that 
has an indirect role in initial attachment via release of extracellular DNA (Qin et al. 
2007) and a direct role by binding to the extracellular matrix protein Vn and plasma 
(Hirschhausen et al. 2010; Mack et al. 2013). Mature GehD protein binds to collagens 
type I, II, and IV (Bowden et al. 2002) SdrF adheres to collagen I via its B domain 
(Arrecubieta et al. 2009; Mack et al. 2013). 
Another important factor is extracellular matrix binding protein (Embp) which has Fn 
binding activities (Büttner et al. 2015). 
 
 
Figure 1.5. Schematic of mechanisms of initial attachment of S. epidermidis by different 
proteins. The surface of medical devices covered by extracellular matrix proteins (ECM 
proteins) such as fibrinogen (Fg), collagen, fibronectin (Fn) and vitronectin (Vn), 
thrombospondin after implantation. S. epidermidis by different proteins (MSCRAMMs) attach 
to these ECM proteins. For example, AtlE binds to Vn, SdrF is a collagen binding protein 
(Mack et al. 2013).   
 
SdrG (Fbe) is a surface-associated fibrinogen binding protein, which binds to host 
proteins by sharing a similar domain structure in its N-terminal A domain (Sellman et 
al. 2008). 
SesC, a surface protein, can be also involved in the binding of S. epidermidis to 
fibrinogen (Shahrooei et al. 2009). 
To initiate attachment, the bacterial cells must be brought in close proximity with the 
conditioned surface. Transportation of cells to the surface can occur by processes such 
as liquid flow or Brownian motion (Habimana et al. 2014). 
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1.4.2 Accumulation phase 
After attachment, S. epidermidis bacteria first grow two-dimensionally on the 
device surface, and subsequently accumulate vertically to achieve a multilayer biofilm 
with three-dimensional structure (Stewart et al. 2015).  
After forming an early adherent monolayer, staphylococcal bacteria multiply locally 
and then reach a mound-shaped cellular aggregation, which is named microcolony. The 
sessile growth mode of staphylococci is mediated by secreted or surface 
macromolecules. These macromolecules or extracellular polymeric substance (EPS) 
(Stewart et al. 2015) may vary between species or even within a strain depending on 
growth conditions. According to the type of EPS, three accumulation types have been 
determined for staphylococcal biofilm formation: PIA-dependent/ica-mediated, 
proteinaceous, and extracellular DNA (eDNA)-based biofilm growth.  
1.4.2.1 ica-mediated biofilm development 
In this mechanism of cell accumulation, production of extracellular 
polysaccharide intercellular adhesin (PIA) (Figure 1.6a) mediates the cell-cell 
interaction after the formation of an adherent monolayer. The formation of PIA, also 
termed polymeric N-acetyl-glucosamine (PNAG), is encoded by the icaADBC operon, 
the expression of which can be regulated by the regulatory gene product, IcaR (Figure 
1.6b). This is the currently best understood biofilm mechanism in staphylococci (Calà 
et al. 2015). 
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Figure 1.6. The exopolysaccharide PIA/PNAG. The Ica proteins are encoded by the ica gene 
locus, which contains the icaADBC operon that generates PIA/PNAG. The icaR gene encodes a 
regulatory protein, IcaR, which regulates the icaADBC operon. The exopolysaccharide 
PNAG/PIA, a partially deacetylated β-1,6-linked N-acetylglucosamine homopolymer, is 
synthesized by the membrane-located N-acetylglucosamine transferase IcaA that needs the 
accessory IcaD membrane protein for its activity. The growing PNAG/PIA chain is exported by 
the IcaC membrane protein. After exportation, the surface-located IcaB de-acetylase, removes 
some of the N-acetyl groups, giving the polymer a cationic character that is essential for surface 
attachment (Otto 2009). 
 
IcaA, C and D are membrane-associated proteins, whilst IcaB is mainly found in the 
extracellular region. IcaA possesses N-acetylglucosamine transferase activity, utilizing 
UDP-N-acetylglucosamine as a substrate, and only reaches optimal activity in the 
presence of IcaD (Figure 1.6a) (Otto 2009).   
The presence of IcaAD alone can only produce oligomers of up to a maximum of 20 N-
acetylglucosamine residues, and IcaC is required for the synthesis of longer chains 
(Gerke et al. 1998). Furthermore, IcaC is also presumed to translocate PIA to the cell 
surface. IcaB partially deacetylates PIA, which is a necessary process for attachment of 
PIA to the cell surface for biofilm formation.  
S. epidermidis PIA-dependent biofilms can be liberated/disintegrated by treatment with 
sodium metaperiodate in vitro (Kogan et al. 2006).  
1.4.2.2 Proteinaceous biofilm accumulation 
PIA, however, seems not to be the only factor for biofilm formation in 
staphylococci, as biofilm formation has been demonstrated in strains lacking the ica 
genes. Biofilm formation in these strains seems to be mediated exclusively by specific 
surface proteins such as accumulation-associated protein (Aap) and biofilm-associated 
protein Bhp (Bap in S. aureus). Indeed, in proteinaceous biofilm, surface proteins 
mediate the cell-cell interaction of adherent monolayers. Aap through repeating G5 
domains (five conserved glycine amino acids) contributes to attachment of the cells and 
also by forming fibrils on the cell surface helps the accumulation phase (Figure 1.7) 
(Speziale et al. 2014). Some of these surface proteins are characterized by an N-
terminal signal peptide and a C-terminal LPxTG motif (Leu- Pro- X-Thr-Gly; where X 
means any amino acid), followed by a hydrophobic domain and positively-charged tail 
(Figure 1.8) (Otto 2009; Kogan et al. 2006). Bhp is an LPxTG protein that promotes 
primary attachment to abiotic surfaces and intercellular adhesion and also helps the 
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accumulation phase (Calà et al. 2015). In this mechanism, sortase enzyme cleaves the 
LPxTG motif and bind the N-terminal part of the protein to the cell wall peptidoglycan 
(Otto 2009; Schneewind & Missiakas 2012).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7. Schematic overview of the S. epidermidis cell surface. Cell surface proteins harbor 
a characteristic LPXTG motif at the C-terminus link to the peptidoglycan (Otto 2009). 
 
After cleavage of the precursor by sortase A in S. epidermidis, the surface proteins 
which harbor a characteristic LPxTG motif at the carboxyl group, bind by its threonine 
and the glycine to an acyl-enzyme intermediate between the active site of sortase A and 
the carboxyl group of threonine at the C-terminal end of the surface protein. The amino 
group of cell wall crosses to lipid II by the C-terminal threonine (Figure 1.8) (Bierne & 
Dramsi 2012). 
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Figure 1.8. Schematic representing the role of sortase A in anchoring LPxTG proteins to 
the peptidoglycan layer of the Gram-positive bacteria. In S. epidermidis, surface proteins are 
synthesized in the cytoplasm including an LPxTG motif, hydrophobic domain and positively 
charged tail (Schneewind & Missiakas 2012).	
	
 Extracellular matrix binding protein (Embp) is another important protein that 
contributes in the accumulation phase of proteinaceaus biofilm formation. This protein 
exists in the cell wall of S. epidermidis and helps to protect these bacteria from 
phagocytosis by macrophages (Christner et al. 2010). Although its exact role is not 
clear, it is shown that the presence of Embp in S. epidermidis is sufficient and necessary 
for biofilm formation by using defined Embp-positive and -negative S.  epidermidis 
(Christner et al. 2010). Proteinaceous biofilms can be decomposed by proteinase K 
(Fredheim et al. 2009).		
1.4.2.3 eDNA biofilm formation 
A third adhesive element that allows cells to accumulate in a staphylococcal 
biofilm is extracellular DNA. eDNA is partially acquired by autolysis of cells within 
the biofilms. In Staphylococcus epidermidis 1457, autolysin E (encoded by atlE) 
activity mediates production of eDNA, and mutants lacking AtlE form significantly less 
biofilm (Mann et al. 2009; Qin et al. 2007). In several reports, eDNA was shown to be 
involved in different stages of biofilm formation of some Gram-positive bacteria, 
including initial adhesion by favorable acid-base interactions, aggregation, biofilm 
architecture, and mechanical stabilization of biofilms. Whilst the precise mechanism of 
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eDNA-mediated biofilm formation is unclear (Das et al. 2010; Hu et al. 2012; Peterson 
& Mei 2013), it is known that DNase I can disperse this kind of biofilm formation. 
1.4.3 Biofilm maturation 
The maturation phase in staphylococcal biofilm comprises the structural formation 
of channels and holes between each biofilm cluster which allows the deep cell layers to 
get the necessary nutrients (Figure 1.4.) (Otto 2013). 
The known factors secreted during biofilm maturation are phenol-soluble modulins 
(PSMs), which contain two-subclasses, α and β. The β subclass has surfactant-like 
properties that promote the biofilm structuring (Wang et al. 2011). Deletion of a class 
of PSM peptides (PSMα, PSMβ) significantly affects biofilm mass thickness, 
roughness, and channel formation, showing that the presence of PSM peptides is 
important for the development of biofilm (Otto 2013). 
PSMs have recently emerged as a novel toxin family defining the virulence potential of 
highly aggressive staphylococci. They have multiple roles in staphylococcal infections, 
such as lysis of red and white blood cells, stimulating inflammatory responses and 
contributing to biofilm development and the dissemination of biofilm-associated 
infections (Figure 1.9) (Peschel & Otto 2013; Cheung et al. 2014).  
 
Figure 1.9. Overview of PSM activities. PSMs have different functions, which help in biofilm 
structuring, detachment, spreading on surfaces, and cytolysis. α-type PSMs have cytolytic 
activity such as lysis of erythrocytes and neutrophils. PSMs also help to escape from innate host 
defense by induction of a tolerogenic phenotype in dendritic cells (DCs) and inhibiting T helper 
1 cell differentiation (Peschel & Otto 2013). 
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In S. epidermidis, PSMs are secreted with an amino terminal N-formyl methionine (fM) 
which leads to neutrophil activation, chemotaxis and cytokine release (Peschel & Otto 
2013). Expression of PSM can also cause biofilm dispersal by the detachment of cells, 
which is a key mechanism leading to the systemic dissemination of infections involving 
biofilms (Figure 1.9) (Vuong et al. 2004; Peschel & Otto 2013). 
Another factor is Arginine Deiminase (ADI) that functions to boost the biofilm 
maturation phase by pH homeostasis in S. epidermidis. Deletion of the arc gene, 
encoding ADI in S. epidermidis 1457 cause the reduction of biofilm by decreasing of 
the pH, viability, and ammonia synthesis in the biofilm formation (Lindgren et al. 
2014). 
Bacterial growth in biofilm is different from exponential growth in planktonic mode. 
Bacterial cells in biofilms shift their physiology towards an anaerobic or microaerobic 
metabolism. It has also been shown that arginine metabolism is an important factor 
during this metabolic shift by serving as a sole carbon source (Fey & Olson 2011). 
In S. epidermidis and S. aureus, other polymers such as teichoic acids also help biofilm 
structuring. They interact via electrostatic interaction with other surface proteins; 
together they make a complex network in the staphylococcal cell surface (Otto 2013). 
Extracellular DNA (eDNA) also helps to order the biofilm structure. The negative 
charge of DNA may interact with other surface structures and change the type of 
biofilm (Otto 2013). 
Changing pH during biofilm maturation affects the EPS structures. In fact, EPS is 
unstable at low pH (lower than pH~ 7). Low pH solubilizes the matrix and triggers 
disassembly of S. epidermidis biofilm (Stewart et al. 2015). 
The presence of other environmental stresses such as high temperatures (fever), the 
existence of sub-inhibitory concentrations of antibiotics and osmolarity, affect the 
quality of biofilm clustering and tend to detach the cells (Boles & Horswill 2011). 
1.4.4 Detachment and possible return to the planktonic growth mode 
From a mature biofilm, cells may disperse and return to a planktonic mode of 
growth, thus completing the biofilm life cycle. The detachment of bacterial cells from 
biofilms is of fundamental importance to the dissemination of infection and to 
contamination in both clinical and public health settings (Sauer et al. 2002; Stoodley et 
al. 2001).  
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It is thought that detached cells express a transitional phenotype between sessile and 
planktonic states during the first hour after detachment, displaying similar growth 
kinetics and cell-surface properties as attached biofilm cells (Rollet et al. 2009). 
Dispersal of cells from biofilms can be caused by external perturbations such as 
mechanical force or by internal biofilm processes.  
The internal factors can be due to the nature of genetic regulation of biofilm such as agr 
quorum sensing system, PSMs and etc. (Wang et al. 2011). The quorum sensing-
regulated PSMs, can disrupt non-covalent, electrostatic or hydrophobic interactions and 
lead to bacterial detachment (Ymele-Leki & Ross 2007).  
Environmental factors that can cause biofilm detachment, are: I) factors influencing 
metabolic activities of bacteria, i.e. starvation of bacteria due to absence of nutrients, 
limitation of O2 accessibility (Donlan & Costerton 2002); II) factors causing lysis of 
biofilm-embedded cells or bacterial death such as exposure to antimicrobial agents; III) 
factors causing loss of biofilm EPS such as EPS-modifying or -degrading enzymes 
secreted by the biofilm-embedded bacteria; IV) presence of surfactants produced by 
CoNS; and V) the presence of shear stress (Hall-Stoodley et al. 2004).  
 
 Genetic regulation of staphylococcal biofilm formation 1.5
Regulation of biofilm formation in staphylococci may vary between strains, but 
the main identified regulators are IcaR, SigB, TcaR, quorum-sensing system, SarA 
family (such as SarA, SarX, SarZ), ArIR-ArIS two-component system (TCS) and some 
of the surface proteins. Below, these regulators are briefly described. 
1.5.1 Regulation by IcaR  
Regulation of the ica operon, expression of which results in PIA production (in 
ica- dependent biofilm), is controlled by the DNA-binding protein IcaR that down 
regulates IcaADBC protein expression (Jefferson et al. 2004).	Activation of icaADBC 
can occur through environmental stimuli in an IcaR-dependent manner: addition of 
sodium chloride or ethanol represses IcaR and consequently enhances icaADBC 
expression. Furthermore, this regulation is controlled by SarA regulator and the global 
regulatory protein SigB and its activator RsbU, through an unknown pathway (Handke 
et al. 2007; Jäger et al. 2005) (Figure 1.10a,b). 
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Figure 1.10. a. Genetic regulations of ica-dependent biofilm formation; b. biofilm mechanisms 
in staphylococci (O’Gara 2007). 
 
 
1.5.2 Regulation via SigB 
There are currently four identified sigma factors in staphylococci (Pintens et al. 
2008); SigA is responsible for transcription of housekeeping genes, SigB is responsible 
for the transcription of stress response genes, SigS controls expression of genes 
required for overall fitness and survival, and SigH (Tao et al. 2010) has a demonstrated 
involvement in competence and prophage integration and excision (Shaw et al. 2008). 
SigB is an alternative factor present in different Gram-positive bacteria and sigB operon 
in S. epidermidis consists of four open reading frames (ORFs): rsbU, rsbV, rsbW and 
sigB (Knobloch et al. 2001). 
SigB in S. epidermidis and S. aureus controls expression of the ica operon by 
repressing transcription of icaR and induces biofilm formation under stress conditions 
such as heat, high osmolarity, high ethanol concentrations, high and low pH as well as 
oxidizing agents (Pintens et al. 2008; Knobloch et al. 2004). Deletion of sigB in S. 
epidermidis reduces biofilm production as repression of ica operon by IcaR occurs 
(Figure 1.10) (Knobloch et al. 2001). 
SigB and RsbU regulate the biofilm development of S. epidermidis during global stress. 
Induction of biofilm by NaCl impairs in S. epidermidis rsbU mutants, whereas ethanol 
doesn't affect the activity of this biofilm. Ethanol has a negative impact on icaR via 
SigB and induces biofilm formation (Figure 1.10a) (O’Gara 2007). 
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1.5.3 Quorum-sensing systems 
Quorum sensing (QS) is an intercellular signaling activity responsive to the 
limitation of nutrients or an increment in bacterial aggregation in the biofilm cluster 
(Mack et al. 2007). It has been demonstrated that bacteria with QS systems have more 
activation of virulence and viability linked genes than non-QS bacteria (Olson et al. 
2014).	Biofilm thickness in S. epidermidis is regulated by two QS systems, namely the 
accessory gene regulator (Agr) and the S-ribosyl-homocysteine lyase (LuxS) system 
(Olson et al. 2014). 
1.4.2.4 The accessory gene regulator quorum-sensing system (agr) 
The Agr-QS is identified as an accessory regulator in staphylococcal biofilm.	
This regulatory system has a central role in the pathogenesis of S. epidermidis (Zhang 
& Ji 2004). The agr complex is approximately 3 kDa in size and comprises two primary 
transcripts, RNAII and RNAIII, which originate from the P2 and P3 promoters, 
respectively (Figure 1.11) (Kong et al. 2006; Novick & Geisinger 2008). 
 
Figure 1.11. The agr gene regulator system in S. epidermidis. In S. epidermidis as in S. 
aureus, Agr-QS regulates by the production of an autoinducer the P2 promoter and the P3 
promoter for transcription of RNAIII. AIPs in S. epidermidis induce phosphorylation of the 
cytoplasmic histidine protein kinase (HPK) domain of the agr signal receptor, AgrC. Then the 
phosphate transfers to AgrA. AgrA in turn activates transcription from the two agr promoters 
(Cegelski et al. 2008). 
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The P2-controlled agr operon encodes four proteins, AgrA, -B, -C, and -D. AgrD is a 
membrane protein of which the N-terminal portion is anchored in the membrane by an 
amphipathic helix that is required for its function and its stability. AgrD has been 
considered as a pheromone because it signals the state of cell density to all members of 
the bacterial biofilm (Novick & Geisinger 2008). AgrB is a multipass integral 
membrane peptidase that is - in cooperation with the signal peptidase SpsB - 
responsible for exporting and processing AgrD to its active form, namely the auto-
inducing peptides (AIP). Within the signal molecule a thiolactone bond between the 
internal conserved cysteine and the carboxyl terminus is formed giving rise to mature 
cyclic AIP (Yarwood & Schlievert 2003; Zhang & Ji 2004).  
The staphylococcal AIP binds to a transmembrane protein, AgrC. AgrC and AgrA 
constitute a two-component regulatory system. AgrC is a sensor kinase, which has an 
N-terminal trans-membrane and a C-terminal domain that is phosphorylated upon 
ligand binding. AgrA acts as a response regulator with recognition sites in the promoter 
regions of RNAIII. When the concentration of AIP in the medium is high, a signal 
transduction cascade is started and, AgrA is activated via phosphorylated AgrC. The 
DNA binding activity of AgrA will induce transcription from the P2 and P3 agr 
promoters in the late-log phase of growth (Novick & Geisinger 2008; Olson et al. 2014; 
Koenig et al. 2004) (Figure 1.11).  
One of the few toxins produced by S. epidermidis is δ-toxin, also called phenol-soluble 
modulin γ (PSMγ), which is encoded by the hld (hemolysin D) gene. This gene is 
included in the RNAIII transcript that acts as the effector molecule for the agr system. 
Increasing transcription from the P3 promoter, increases the levels of the regulatory 
RNAIII and concurrently of δ-toxin (Olson et al. 2014). 
It is observed that agr mutants form thicker biofilms; this increased biofilm thickness is 
not attributed to cell growth or death, but the inability of cells to detach from the mature 
biofilm. (Yarwood & Schlievert 2003; Kong et al. 2006). 
Deletion of agr in the sigB mutant compensates the biofilm decrease. Moreover, SigB 
represses the agr system by targeting the P3 promoter and thus the expression of 
RNAIII (Knobloch et al. 2001). 
1.4.2.5 luxS quorum-sensing system 
luxS-QS system is present in both Gram-negative and -positive bacteria, but its 
function in staphylococci is poorly understood. LuxS is an enzyme, which catalyzes the 
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conversion of S-ribosyl-homocysteine to homocysteine and 4,5-dihydroxy-2, 3-
pentanedione (DHPD), which is the precursor of autoinducer-2 (AI-2).	 In S. 
epidermidis, AI-2 is mainly produced during the logarithmic growth phase, and 
synthesis is reduced in the stationary phase (Li et al. 2008). Once a threshold level is 
reached, it acts as a signal which activates the AI-2-specific sensor/regulator system, 
which in turn directs the expression of various virulence-associated genes (Daniels et al. 
2004). 
Testing an isogenic luxS mutant strain in S. epidermidis demonstrated that luxS 
signaling is functional in S. epidermidis biofilm formation (Xu et al. 2006). The mutant 
strain showed an increase of biofilm formation in vitro and enhanced virulence in a rat 
model of biofilm-associated infection compared to the wild type. It was shown	that AI-2 
regulates the biofilm pathway of S. epidermidis by enhancing the transcription of the 
ica operon (Xue et al. 2015). 
1.5.4 Regulation by SarA family 
SarA is a transcriptional regulator encoded by sarA (staphylococcal accessory 
regulator A) gene (Conlon et al. 2004). The SarA family in S. epidermidis consists of 
different DNA-binding paralogs. Besides SarA, this family includes SarR, SarT, SarU, 
SarS, SarV, SarZ, SarX, Rot and MgrA (alternatively known as Rat). The transcription 
of these regulators is strongly dependent on the growth phase (Arciola et al. 2012).  
SarA is an essential positive regulator for PIA dependent biofilm (Martı & Penade 
2005), but negatively regulates the eDNA biofilm in S. epidermidis (Christner et al. 
2012).   
It is demonstrated that SarA directly regulates icaADBC transcription and thus regulates 
PIA production in a SigB-independent way in S. epidermidis (Handke et al. 2007).  
SarA regulates the eDNA biofilm by modulating expression of the 1 MDa extracellular 
matrix binding protein (Embp) and autolysis-dependent release of eDNA (Christner et 
al. 2012). 
Several members of the SarA family are involved in regulation of the agr locus, but 
MgrA is the most important member involved in the activation of the agr system as 
well as in the control by inhibition of the process of cell autolysis (Arciola et al. 2012). 
SarX, a SarA family protein, negatively regulates the Agr system. SarX protein binds 
specifically to the P3 promoter in S. epidermidis. However, it is difficult to correlate 
CHAPTER	I:	General	Introduction	
	 19	
SarX-mediated biofilm regulation with altered Agr because both mutation of sarX and 
overexpression of sarX activate RNAIII transcription (Rowe et al. 2011). 
SarX positively regulates PIA-dependent biofilm. Overexpression of SarX increases ica 
and PIA expression, whereas in sarX mutant, icaA transcription and PIA expression 
were decreased and overexpression of SarX did not promote biofilms in an icaC mutant 
(Rowe et al. 2011).  
SarZ has also been known as an important regulator in S. epidermidis biofilm formation 
and virulence (Wang et al. 2008). SarZ significantly affects the transcription of the 
biosynthetic operon for exopolysaccharide biofilm. SarZ also helps the expression of a 
series of virulence genes, such as genes that influence the expression of lipases and 
proteases, resistance to the human antimicrobial peptide, and hemolysis (Wang et al. 
2008). 
1.5.5 Regulation by TcaR 
The teicoplanin-associated locus regulator (TcaR) is a member of the multiple 
antibiotic resistance regulator (MarR) family that exists in both S. epidermidis and S. 
aureus. It has been shown that this factor is involved in teicoplanin and methicillin 
resistance. By Northern blot analysis, it has been shown that inactivation of tcaR 
increases transcription of icaADBC in S. aureus and in S. epidermidis. Thus, TcaR 
negatively regulates ica operon expression (Jefferson et al. 2004; O’Gara 2007). 
In 2010, Chang et al. reported that six dimers of TcaR are capable of binding three 
DNA segments (33 bp) close to the IcaR DNA-binding region with different affinities 
and their repressor activity is directly interrupted by salicylate and different classes of 
natural antimicrobial agents (Chang et al. 2010). However, deletion of tcaR did not 
have any effect on the rate of PIA production and on the binding of bacteria to the 
polystyrene, while deletion of icaR leads to an enhancement in both attachment and 
PIA biosynthesis. Furthermore, deletion of both icaR and tcaR increases the rate of PIA 
production 100-fold more than in an icaR mutant and 500-fold more than the wild type. 
It was concluded that TcaR is a weak repressor of ica operon transcription while IcaR is 
a strong one (Jefferson et al., 2004). 
1.5.6 Functions of the surface proteins in biofilm formation and infection by S. 
epidermidis 
The staphylococcal surface is decorated with cell wall-anchored (CWA) proteins which 
are covalently bound to the peptidoglycan layer (Foster et al. 2014). In 2005, Bowden et 
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al. characterized eleven genes encoding putative CWA proteins for S. epidermidis. The 
CWA proteins include the MSCRAMMs and the G5-E repeat family, which play both 
an important role in biofilm formation (Figure 1.12).  
So far, the functions of several surface proteins Aap, Bhp, AtlE, SdrF and SdrG were 
described.  
One of the MSCRAMMs, serine–aspartate repeat-containing protein G (SdrG) from S. 
epidermidis has been identified as a fibrinogen-binding protein. The N-terminal A 
region of SdrG contains three subdomains with IgG-folded domains (Bowden et al. 
2008). This protein binds fibrinogen using the 'dock, lock and latch' (DLL) mechanism. 
This binding mechanism involves the docking of the ligand in between two SdrG 
subdomains (N2 and N3) by the movement of a C-terminal extension of one subdomain 
covering the ligand and insertion of a complementary beta-sheet in a neighboring G′ 
strand in the N3 subdomain (Bowden et al. 2008; Foster et al. 2014). 
SdrF, another MSCRAMM, mediates binding to collagen (type I). SdrF, like SdrG, has 
a cell-sorting LPxTG motif, a region that spans the S. epidermidis membrane and a C-
terminal cluster of positively charged residues (Arrecubieta et al. 2007). This protein 
contains additional B-repeats that by using the DLL mechanism bind to the collagen IV. 
This protein also has the N-terminal A region that contains three folded subdomains, 
N1, N2 and N3 (Foster et al. 2014). 
Aap in S. epidermidis and surface protein G (SasG) in S. aureus are proteins that form 
fibrils to promote biofilm formation; the N-terminal of these proteins link to the wall 
and span via Zn2+-dependent G5 domains (Figure 1.12) (Foster et al. 2014; Otto 2009).  
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Figure 1.12. Roles of CWA proteins in biofilm formation. Cell wall-anchored (CWA) 
proteins promote attachment to the surfaces that have been conditioned with host plasma 
proteins. Extracellular DNA that is released by autolysins can promote attachment to 
unconditioned surfaces. When the A domain of Aap of S. epidermidis or S. aureus surface 
protein G (SasG) is removed, the G5–E repeats promote cell–cell aggregation and biofilm 
accumulation. Fibronectin-binding proteins (FnBPs) and other surface proteins promote 
accumulation either by protein–protein interactions.(Foster et al. 2014). 
 
Furthermore, analysis of primary sequences of S. epidermidis demonstrated 7 other 
hypothetical surface proteins (SesA, SesB, SesC, SesE, SesG, SesH and SesI) of which 
the structural formation is very similar to the previously described cell wall-anchored 
proteins of other Gram-positive cocci, especially S. aureus (Bowden et al. 2005). 
However none of the Ses proteins are direct homologues of the S. aureus proteins. 
Secondary and tertiary structure predictions suggest that most of the Ses proteins are 
composed of several contiguous subdomains, and the majority of these predicted 
subdomains are folded into β-rich structures. 
The function of these proteins is not clear yet, but it was shown that sesB, sesC and 
sesE are present in all S. epidermidis strains examined (Bowden et al. 2005; Thomas et 
al. 2014). For sesA, it was also reported that it was present in all S. epidermidis strains 
(Bowden et al. 2005), but some researchers reported strains without sesA (Guss et al. 
2009). 
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The sesI gene is not present in the normal S. epidermidis flora of healthy man, but is 
present in approximately 50 % of clinical isolates causing invasive infections 
(Söderquist et al. 2009).  
Surface proteins in different strains have important roles in biofilm formation; 
Shahrooei et al. tried to determine the roles of these proteins in S. epidermidis 
(Shahrooei et al. 2012). They investigated the expression of these genes during different 
time points of biofilm formation in sessile bacteria compared to their planktonic 
counterparts in S. epidermidis (Shahrooei, 2010). For this study, DNA and RNA were 
extracted from biofilm attached to the seven mm catheter fragments (Arrow 
International, Reading, Pa.) in different time points (0, 10, 35, 60, 120, and 180 min). 
Gene expression was quantified by cDNA/gDNA ratio for each gene and the significant 
differences were quantified (p<0.05; 1-way-ANOVA) at any given time point compared 
with the time point zero (Table 1.1).  
Table 1.1. Gene expression pattern in vitro of ses genes in sessile bacteria compared to 
their planktonic counterparts. ↑: Upregulation, ↔: No changes (Shahrooei, 2010)  
 
Subsequently, Shahrooei (2010) purified polyclonal antibodies against rSes proteins, 
and the effect of these antibodies on the rate of biofilm formation of S. epidermidis was 
evaluated. An antibody against SesC protein could significantly reduce biofilm 
formation by S. epidermidis 10b (Figure 1.13).  
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Figure 1.13. Inhibition of primary attachment of S. epidermidis 10b cells to 
polystyrene in presence of total IgGs purified from pre-immune (□), and anti-whole 
cell (WC) or anti-SesL, K, M, B, C sera (■) (Shahrooei, 2010). Bacteria were mixed 
with IgGs and incubated for 2 h at 4°C and then pipetted into the wells. After 2 h 
incubation at 37°C, plates were washed and stained with crystal violet and the OD595 was 
measured. The error bars indicate standard deviations. Data are the average of 8 
measurements in 2 independent experiments. 
They found also that SesC is a MSCRAMM with the ability to bind to fibrinogen 
(Shahrooei et al. 2009).  
SesC encodes a 676-amino acid (aa) protein with a predicted molecular mass of 75 kDa. 
The cytoplasmic precursor of SesC contains a 35-aa N-terminal signal peptide 
(predicted using the SignalP server at http://www.cbs.dtu.dk /services/SignalP/), a 37-aa 
C-terminal LPxTG sorting signal, and a large extracellular domain. The N-terminal 
signal is required for Sec-dependent secretion and is cleaved by signal peptidase. The 
C-terminal signal is needed for cleavage between the threonine and the glycine of the 
LPxTG motif and for attachment to peptidoglycan by sortase (Shahrooei et al. 2009). 
The understanding of the different mechanisms contributing to biofilm formation can 
help to develop a vaccine against infection by these bacteria and, since the function of 
SesC is not clear yet, in this study we tried to explain the function of this protein.  
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Aims of this study 
For the last few years, bacterial biofilm formation has been considered as one of the 
more important infectious causes of irreparable damage to the environment and 
health. S. epidermidis is one of the prime organisms responsible for damage due to 
biofilm. 
Staphylococcal biofilm formation has a complex molecular mechanism, which has 
only been partly clarified. The roles of some surface proteins in this complex process 
have been determined. 
To date there remain surface proteins in S. epidermidis of which the function is not 
fully understood. Understanding their function could help to find novel strategies to 
combat biofilm formation. 
It was reported that a polyclonal antibody against SesC protein can significantly 
reduce biofilm formation by S. epidermidis. Following this finding, in the present 
study we had the following aims: 
i. To investigate the function of SesC in the biofilm formation of S. 
epidermidis 
ii. To establish a new in vivo model to further evaluate the potential use of 
SesC as a target for vaccine development and its role in device-related 
infection (DRI) in vivo 
iii. To evaluate SesC or other Ses proteins to be used as a potential vaccine 
target 
Taken together, understanding the role of SesC in biofilm formation may help to find 
a way to comprehend S. epidermidis biofilm and by conjugating the best epitopes of 
different proteins we may reach the best antigen to immunize humans against this 
bacterium. 
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3.1 Introduction 
Introduction of mutations is a valuable method to understand the function of 
proteins (Loeb 1989). There are several methods to generate random mutations in a 
specific protein, in addition to a knockout of a target gene or knockdown of mRNA 
by using the Antisense-RNA method (Wagner & Simons 1994). To explain the role of 
SesC, we tried to construct S. epidermidis sesC- mutants. 
3.2 Materials and Methods 
3.2.1 Knockout of sesC 
Conventional mutant strategy was our first attempt to knock out sesC, which started by 
designing and making the relevant cassette gene. 
In this study, a temperature-sensitive E. coli/Staphylococcus shuttle vector pBT2 
(Brückner 1997), was used. First, primers for PCR were designed (Table 3.1) according to the 
genomic sequence of S. epidermidis ATCC12228. Genome regions flanking the sesC gene 
were PCR amplified and ligated into the pGEM-T Easy vector (Promega, Madison, WI). 
Subsequently, the PCR fragments were cloned into pBluescript-II SK vector (Stratagene) 
resulting finally in pBS-sesC-up and pBS-sesC-up/sesC-down, respectively. The tetM gene 
rendering the host cell tetracycline resistant was PCR-amplified using pCN36 (Charpentier et 
al., 2004) as template DNA, then XhoI/ApaI-digested and cloned between sesC-up and sesC-
down in pBS. The BamHI/KpnI-digested knockout cassette sesCup-tetM-sesCdown was next 
inserted into pBT2, yielding pBT2-sesCup-tetM-sesCdown.  
Competent cells for electroporation were prepared by washing exponentially growing cells 
with 10% glycerol. This plasmid was electroporated into different S. epidermidis strains. 
Electroporation was performed at room temperature in a 0.2 cm cuvette (BTX Electroporation 
Cuvettes PlusTM), at a setting of 2.5 kV, 25 µF, 100 ohm for 2.5 ms using a gene pulser 
(BTX Electroporator ECM 630). 
3.2.2 Knock-down of SesC using Antisense RNA  
Antisense RNAs act by shifting their target gene transcription through interference or 
transcription attenuation in bacteria (Thomason & Storz 2010). Some of the antisense 
RNAs can act like trans-encoded sRNAs to block ribosome binding and translation. 
To construct an antisense-RNA, a 372-bp part of sesC was amplified (Table 3.1) and 
cloned into the pLI50 vector (Table 3.2) using restriction site KpnI and BamHI, 
ligated at the 3’ end of plasmid pLI50 and electroporated into S. epidermidis strains 
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st1 (a clinical isolate), TU3298 (Tu), 10b, ATCC12228 and RP62A. The presences of 
plasmid in the transformant strains were confirmed by plasmid extraction. 
 
TABLE 3.1. Primers used in this study. 
 
 
 
 
 
 
 
 
TABLE 3.2. Plasmids used in this study 
 
3.2.2.1 Detection of SesC knockdown 
Western blot analysis of SesC in S. epidermidis clones transformed by antisense-RNA 
was performed as described (Nakashima & Miyazaki 2014). Briefly, bacterial cells of 
10  overnight cultures grown at 37°C in BHI, were harvested by centrifugation, re-
suspended within lysis buffer [10 mM Tris/HCl, 10 mM EDTA, 1 mM phenyl-
methane sulfonyl fluoride (PMSF, pH 7.5), 100 µg lysozyme/, 100 µg lysostaphin/] 
and incubated for 1 h at 37°C. Then, cells were broken by passing through a French 
press at 69 MPa (SLM Aminco) three times and followed by sonication (Bath 
sonicator-Branson 2510, 42 kHz) of samples on ice. Thereafter, soluble proteins were 
Primer Sequence (5’-3’) 
sesC-SF GTTGATAACCGTCAACAAGG  
sesC-SR CATGTTGATCTTTTGAATCCC 
sesC F1 -LL TGCCAAGCAAATTGATGGTCTTGCA 
sesC F2 -LL ACTCTGCGATTGAAGGCAAGGCA 
sesC R1 -LL GCTTGTTGGATTTTGTCAGCGATGG 
tetM  pCN36 F GTTTAACTCGAGACCTAGGCAAATATGCTCTTACGTGC 
tetM pCN36 R CTATGAGGGCCCGCCGCGGAAATATTGAAGGCTAGTCAG 
Up F LL: BamHI ATGGATCCGGTAAACATAAATAGTCCTCCTTCG 
Up R LL: XhoI ATCTCGAGCACATACTCCTTTAATAAAGTTACCT 
Down F LL:  ApaI ATGGGCCCAAGCCAAAACTTGTCGAATTCTC 
Down R LL:KpnI ATGGTACCTCCACAAAATAATAGCACAAAGATG 
sesC- antis-F KpnI ATGGTACCAGTACGACAACAAATCAATCCG 
sesC-antis-R BamHI ATGGATCCTCTTTGTCGGTCAATACTTTGC 
plasmids Characteristic(s) Source or reference 
pGEM®-T Easy Cloning Vector	 Stratagene 
pBluescript II SK Cloning Vector	 Promega 
pCN36 E. coli-Staphylococcus shuttle vector, Apr-Tet (Charpentier et al. 2004)  
pBT2 E. coli-Staphylococcus shuttle vector Apr-Erm (Brückner 1997) 
pLI50 E. coli-Staphylococcus shuttle vector- Apr-Cm (Lee et al. 1991) 
pCN68 E. coli-Staphylococcus shuttle vector- Apr-Erm (Charpentier et al. 2004)  
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separated from the insoluble proteins by centrifugation (13000 rpm 4°C, 5 min). The 
proteins (25 mg) were separated using 12% sodium dodecyl sulphate polyacrylamide 
gel electrophoresis (SDS-PAGE) and electrophoretically transferred onto PVDF 
membranes. The primary antibody (1:5000 dilution of a rabbit anti-SesC polyclonal 
antibody in TTBS) was added to the membranes and incubated overnight in 4°C. 
After three washes with TTBS, secondary antibody (horseradish peroxidase-
conjugated anti-rabbit IgG secondary antibody (1:2500 in TTBS+1% skim milk)) was 
added and incubated for 2 h. Finally, after washing three times, the SesC proteins 
were detected by ECL western blotting detector (AmershamTM, GE Healthcare) in 
combination with a CCD camera to visualize the presence of SesC.   
3.3 Results and Discussion 
The correct cassette pBT2-sesCup-tetM-sesCdown was made in E. coli DH5α, 
however, transformation in S. epidermidis was not successful and we have not 
succeeded in knocking out of sesC using this strategy.  
The second strategy, antisense RNA, also didn’t work. Western blots showed no 
changes in expression of SesC in transformant S. epidermidis strains in comparison 
with their parental strains (Figure 3.1). 
 
 
Figure 3.1. Immunodetection of SesC in S. epidermidis strains st1 (a clinical isolate) and 
TU3298 (Tu), and their respective transformants containing pLI50-antisense sesC. 
 
Uptake of foreign DNA by S. epidermidis is not easy, possibly because of the 
presence of a CRISPR/Cas system in these bacteria (Figure 3.2). CRISPR loci 
produce CRISPR RNA which after transcription, hybridizes to the foreign DNA 
sequences and cleaves it (Otto 2012). Another explanation is that the sesC gene may 
be an essential gene for this strain. 
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Figure 3.2. Transferring genes between S. epidermidis and S. aureus are subject to 
CRISPR/Cas interference. S. aureus produces a large variety of toxins from mobile genetic 
elements in opposition to S. epidermidis, which lacks these genes. The CRISPR/Cas system in 
S. epidermidis destabilizes the foreign DNA (Otto 2012) . 
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4.1 Introduction 
S. epidermidis being a prominent bacterial species of the normal human skin 
microbiota is nowadays recognized as an important opportunistic pathogen, which can 
easily attach to medical devices and consequently cause severe infections. Globally, 
S. epidermidis represents the most frequent (about 75% to 90%) species among the 
coagulase-negative staphylococci (CoNS) isolated from clinical samples and is the 
most common source of infections on indwelling medical devices (Piette et al. 2009; 
Sarathbabu 2013). 
Since identification of these bacteria based on morphology and biochemistry is 
laborious, and regular diagnosis of a bacterial infection can take some days or even 
longer after sampling, a rapid and reliable technique to identify this bacterium is most 
necessary.  
In recent years, a most commonly used method to identify and screen bacterial 
isolates is PCR amplification of a species-specific marker gene (Järvinen et al. 2009). 
PCR is a simple method which can be carried out immediately on a sample without 
prior DNA purification, using a single colony (Sheu et al. 2000). The marker gene 
envisaged is a species-specific, conserved gene of which the presence is most 
probably essential within that species. If such gene is found, the conserved sequence 
can be exploited to identify the matching bacterial species (Zeigler 2003). 
In this study, we investigated if sesC is such a gene, which specifically marks S. 
epidermidis strains or isolates and can be used for the identification of these bacteria. 
sesC encodes Staphylococcus epidermidis surface protein C (SesC) which consists of 
676 amino acids including a sortase-recognized LPxTG motif (Bowden et al. 2005). It 
has previously been demonstrated that the SesC protein is more strongly expressed in 
S. epidermidis biofilm-associated than in planktonic cells.  
 As S. epidermidis causes frequently biofilm-related infections for which culturing is 
difficult, this strengthened the choice of sesC as a candidate marker gene. This idea 
was further supported by the fact that sesC could not be deleted in an attempt to get 
insight in its function, suggesting it might be essential for the viability of the species. 
In addition, in silico genome analyses did not reveal homologous genes in other 
staphylococci. All these findings suggested that sesC could be used as a genetic 
marker for S. epidermidis. 
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4.2 Materials and Methods 
4.2.1 Bacterial strains and growth media  
A total of 438 clinical staphylococcal isolates derived from different infection or 
bacteremia sources from different patients, were collected from the University 
Hospital Leuven – Gasthuisberg and first identified by mass spectrometry (MALDI 
TOF, Bruker) which is an accurate genotypic identification system (99.3% of strains 
correctly identified) (Loonen et al. 2012), then went through the VITEK® 2 
identification system (BioMérieux) (100% of strains correctly identified when both 
methods are performed simultaneously) (Loonen et al. 2012). All Staphylococcus spp. 
were grown in Brain Heart Infusion medium (BHI, Oxoid) or Tryptone Soya Agar 
(TSA, Oxoid).  
4.2.2 Primers  
All primers used in this work, are represented in Table 4.1. They were designed with 
Primer Express 2.0 software (Applied Biosystems, USA) and purchased from 
Eurogentec (Seraing, Belgium). sesC-related primers were all based on the genomic 
DNA sequence of S. epidermidis ATCC 12228 as available in the National Center for 
Biotechnology Information (NCBI) databank. (Gene ID of sesC (SE2232): 1056520; 
protein accession no. NP_765787.1).  
 
Table 4.1 Primers used in this study. 
 
Primer Sequence (5’-3’) 
sesC-F1 GTTGATAACCGTCAACAAGG  
sesC-F2  TGCCAAGCAAATTGATGGTCTTGCA 
sesC-F3 ACTCTGCGATTGAAGGCAAGGCA 
sesC-R1 CATGTTGATCTTTTGAATCCC 
sesC-R2 GCTTGTTGGATTTTGTCAGCGATGG 
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4.2.3 Colony PCR  
In order to perform colony PCR, bacterial isolates were grown overnight on TSA 
plates, a single colony was picked by sterile pipet tip (without touching the TSA agar) 
and cells were suspended in 20 µl of sterile distilled water. Then, 4 µl of this bacterial 
suspension was added as DNA template to a PCR tube containing 5 µl of 2x PCR 
Master Mix (Promega) and 0.5 µl of sesC-F1 and sesC-R1 primers rendering the final 
sample volume of 10 µl. The following PCR conditions were applied to amplify the 
sesC region using the GeneAmp® PCR System 9700 thermal cycler (Applied 
Biosystems): 94°C for 5 min, followed by 30 cycles of 30 seconds at 94°C, 30 sec at 
55°C, and 1 min at 72°C, and at last a final extension step at 72°C for 7 min. 
Appropriate positive and negative controls were included to compare the efficiency of 
amplification and to prove the absence of significant PCR inhibition. 
In order to determine the sensitivity of the colony PCR assay, 2-fold serial dilutions of 
reference S. epidermidis ATCC 12228 were used to discover the minimal number of 
genomes, which could be identified (Khodaparast et al. 2016a). 
4.2.4 Sequencing of sesC amplicons 
The entire sesC gene was sequenced for five different S. epidermidis strains. 
Therefore, genomic DNA was extracted from each isolate using a ‘Wizard genomic 
DNA purification kit’ (Promega) with the addition of 30 µg lysostaphin (AMBI) –1 in 
the lysis step. The sequencing was performed using sesC-F1, sesC-F2, sesC- F3, 
sesC-R1, and sesC-R2 primers (Table 4.1) on a ABI PRISM® 310 Genetic Analyzer 
(Applied Biosystems) according to the manufacturer's instructions. A protein 
homology analysis was performed using the BLASTP program (Altschul et al. 1990). 
4.3 Results and Discussion  
4.3.1 Identification of staphylococcal isolates 
From the 438 clinical Staphylococcus isolates taken from patients, 175 isolates were 
identified as S. epidermidis and of the remaining isolates, 33 were identified as 
methicillin-resistant Staphylococcus aureus (MRSA), 50 isolates as methicillin-
sensitive Staphylococcus aureus (MSSA). The 180 other isolates were CoNS 
including 43 Staphylococcus haemolyticus, 40 Staphylococcus hominis, 29 
Staphylococcus warneri, 19 Staphylococcus capitis, 12 Staphylococcus pasteuri, 11 
CHAPTER	IV:	sesC	as	a	genetic	marker	for	identification	of	Staphylococcus	epidermidis		
	
	 35	
Staphylococcus lugdunensis strain, 9 Staphylococcus saprophyticus, 6 Staphylococcus 
intermedius, 4 Staphylococcus carnosus, 3 Staphylococcus xylosous, 3 
Staphylococcus simulans, 1 Staphylococcus pseudintermedius. Table 4.2 shows the 
best matching NCBI strains as determined by mass spectrometry (WALDORF, 
Bruker).  These strains all have different antibiotic susceptibility patterns (listed in the 
Table 4.4). 
 
Table 4.2 List of strain-types achieved from the best rank of MALDI-TOF MS (Bruker) 
 
Number of strains	 Best match type-strains	
n= 49 Staphylococcus epidermidis 10547 CHB 
n= 32 Staphylococcus epidermidis DSM 3269 
n= 26 Staphylococcus epidermidis 4b-r ESL 
n= 24 Staphylococcus epidermidis 6b-s ESL 
n= 18 Staphylococcus epidermidis ATCC 14990 T TH2 
n= 11 Staphylococcus epidermidis CCM 4505 
n= 4 Staphylococcus epidermidis sk 135 hits 
n= 4 Staphylococcus epidermidis BCM-HM p0060 
n= 3 Staphylococcus epidermidis LMG 10474 
n= 3 Staphylococcus epidermidis ATCC 12228 THL 
n= 1 Staphylococcus epidermidis JCM 2414 
 
4.3.2 Exclusive presence of sesC in S. epidermidis isolates 
Colony PCR on all staphylococcal strains using sesC-specific primers revealed that 
sesC was exclusively present in the isolates identified as S. epidermidis, while for the 
other strains no sesC-related PCR product could be obtained (Figure 4.1). Thus, using 
the sesC gene as a marker, we were able to easily distinguish S. epidermidis isolates 
from other species.  
Recently, Thomas et al. reported 6 sesC-negative strains among 129 S. epidermidis 
isolates (Thomas et al. 2014). However, these sesC-negative strains proved to be 
sesC-positive on further examination (Robinson, D.A., Pers. Comm).  
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Noteworthy, another S. epidermidis surface gene, namely sesI, was earlier reported to 
be exclusively linked to invasive S. epidermidis strains. The sesI gene could not be 
detected among strains of the skin microbiota, while it was present in about 50% of 
the S. epidermidis cultures isolated from invasive infections (Söderquist et al. 2009). 
 
	
 Figure 4.1 Example of colony PCR amplification using sesC-F1/R1 primer pair on 
different staphylococcal strains. Lanes 1-12, S. epidermidis isolates/strains; 13, negative 
control without template DNA; 14, positive control; 15, S. aureus MSSA; 16, S. aureus 
MRSA; 17-18, S. hominis; 19-20, S. haemolyticus; 21-22, S. warneri; 23-24, S. capitis; 25, S. 
saprophyticus; 26, S. pasteuri; 27-28, S. epidermidis ATCC 12228 and 10b. SL, Smart-ladder 
molecular size marker (Eurogentec) 
 
4.3.3 Sequencing of sesC 
Nucleotide sequencing of the sesC gene of 5 S. epidermidis isolates revealed that the 
nucleotide sequence of the homologous genes were 96% to 99% identical to sesC of 
S. epidermidis ATCC 12228 (Table 4.3). These results suggest that the sesC gene has 
become a conserved DNA sequence in all S. epidermidis strains, but absent in other 
staphylococcal species. Therefore, it can be used as a marker to screen S. epidermidis 
from other microorganisms. 
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PCR-based identification is an easier, faster and cheaper way for identification 
compared with those two techniques together, VITEK and MALDI-TOF. Of course, 
these systems are expensive and they are not available in every laboratory. To know a 
cheaper and faster technique like PCR-based would be helpful to the diagnosis of the 
early phase of infection and to prevent the severity of infection in the patient. 
Taken together, sesC may be essential for viability and seems to be a unique genomic 
feature of this bacterial species. We demonstrated that a colony PCR assay based on 
the sesC gene might be a very useful tool for the reliable identification of S. 
epidermidis strains. PCR-based identification is an easier, faster and cheaper way for 
identification compared with alternative techniques, like VITEK and MALDI-TOF. 
These systems are expensive and thus not affordable for every laboratory, especially 
not in developing countries. The PCR-based identification will potentially improve 
the diagnosis of biomaterial-related infections and decrease the time to identification. 
Consequently, it would be helpful to the diagnosis of the early phase of infection, and 
to prevent the severity of infection in the patient. 
Nevertheless, screening of more clinical isolates belonging to a broader range of 
staphylococcal strains, may be advisable to further validate the outcome of this study. 
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Table 4.3 Differences in amino acid sequence between SesC of S. epidermidis ATCC 12228 
and of the S. epidermidis isolates S32, S146, 10b and S64, as deduced from DNA sequence 
analysis. (Substituted residues in SesC homologs are indicated in bold) 
 SesC from  
Aa number ATTC 12228 S32 S146 10b S64 
156 N E N N N 
123 K N K K K 
157 S R S S S 
212 K N K K K 
214 L P L L L 
255 R H R R R 
262 I I I I L 
310 S S P S S 
325 S S S S A 
401 R R R R Q 
554 K K K E K 
613 S S S P S 
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Table 4.4.	Patients information and antibiogram pattern of the strains used in this study. 
 
CHAPTER	IV:	sesC	as	a	genetic	marker	for	identification	of	Staphylococcus	epidermidis		
	
	 40	
 
CHAPTER	IV:	sesC	as	a	genetic	marker	for	identification	of	Staphylococcus	epidermidis		
	
	 41	
 
 
CHAPTER	V:	The	Possible	Role	of	S.	epidermidis	LPxTG	Surface	Protein	SesC	in	Biofilm	Formation	
	 42	
 
CHAPTER V: The Possible Role of Staphylococcus 
epidermidis LPxTG Surface Protein SesC in Biofilm 
Formation 
	
	
	
CHAPTER	V:	The	Possible	Role	of	S.	epidermidis	LPxTG	Surface	Protein	SesC	in	Biofilm	Formation	
	 43	
5.1 Introduction 
Of all coagulase-negative staphylococci, S. epidermidis is the most common cause of 
infections associated with catheters and other indwelling medical devices (O’Gara & 
Humphreys 2001; Otto 2009). It is a permanent and ubiquitous colonizer of human skin, can 
easily contaminate the medical devices during insertion, and subsequently form a biofilm 
(Otto 2009; Uçkay et al. 2009). The capacity to form a biofilm is considered as one of the 
major virulence factors of this bacterial species (Raad et al. 1998; Götz 2002). 
Staphylococcal biofilms develop via a multifactorial process, which may differ between 
species and strains. Nevertheless, most of the factors involved are analogous in S. 
epidermidis and S. aureus and have a similar function in biofilm formation (O’Gara & 
Humphreys 2001; Otto 2009; Uçkay et al. 2009).   
Up to now, based on extracellular matrix macromolecules constituting the biofilm, three 
mechanisms of biofilm formation in staphylococci are identified (Rawlinson et al. 2011). 
Production of polysaccharide intercellular adhesin [PIA, also called poly-N-
acetylglucosamine (PNAG)] was the first and for a long time, the only mechanism of 
biofilm formation identified (O’Gara 2007; Cheung & Otto 2010). Further studies showed 
the existence of other PIA- or ica-independent mechanisms in S. aureus and S. epidermidis. 
Based on in vivo and in vitro studies, the proteinaceous biofilm formation was identified. In 
this case, the cell-surface and cell-cell attachment is based on proteins (Fitzpatrick et al. 
2005; Hennig et al. 2007). More recently, a third mechanism based on extracellular DNA 
(eDNA) constituting a cell-to-cell or cell-to-substratum connecting component was 
recognized. This eDNA originates from autolysis (Rice et al. 2007; Büttner et al. 2015).  
It has been shown that staphylococcal surface proteins such as accumulation-associated 
protein (Aap), biofilm-associated proteins (Bap, and Bap homologue Bhp), extracellular 
matrix-binding protein (Embp), fibronectin- or fibrinogen-binding proteins (FnBPA, FnBPB 
and Fbe/SdrG), and the major autolysin (AtlE) mediate the formation of the network of 
multilayered cell clusters and filamentous proteins, and thus play an important role in the 
biofilm accumulation phase (O’Gara 2007; Hennig et al. 2007; Christner et al. 2010; 
Houston et al. 2011). In S. epidermidis and S. aureus, LPxTG motif-containing proteins 
which covalently link to the cell wall via sortase activity, are determinants in the 
pathogenesis of device-related infections (O’Gara 2007).  
Through unknown or not well-characterized mechanisms such as insertion and excision of 
the insertion sequence IS256 at specific hot spots of the S. epidermidis icaA and icaC genes, 
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PIA/PNAG production, biofilm formation and biofilm phenotype may be phase variable, 
allowing to switch from PIA-dependent to proteinaceous phenotype (Ziebuhr et al. 1999) 
(Conlon et al. 2002). In 2001, Knobloch et al. reported that NaCl affects biofilm formation 
through the activation of the sigB operon, an important regulator of the ica operon, and thus 
can be used to distinguish ica-dependent from ica-independent biofilm formation 
(Fitzpatrick et al. 2005; Conlon et al. 2002; Knobloch et al. 2001). By using dispersing 
agents such as sodium metaperiodate (SM), proteinase K (PK) and DNase I, the chemical 
composition of the biofilm extracellular polymeric substance can be determined and one can 
discriminate between PIA-dependent, proteinaceous and eDNA-based biofilms (Fitzpatrick 
et al. 2005; Pozzi et al. 2012). 
So far, the roles of 5 S. epidermidis LPxTG proteins (Aap, Bhp, SdrF, SdrG, SesI) in the 
pathogenesis of S. epidermidis infections and biofilm formation have been studied (Davis et 
al. 2001; Bowden et al. 2005; Arrecubieta et al. 2009). We focused our research on the 
LPxTG motif-containing S. epidermidis surface protein SesC, a 676-amino acid (aa) protein 
with a predicted molecular mass of 75 kDa. The cytoplasmic precursor of SesC contains a 
35-aa N-terminal signal peptide, required for Sec-dependent secretion and is cleaved off by 
the signal peptidase. The 37-aa C-terminal LPxTG-sorting signal is recognized by sortase, 
which will cleave the bond between the Thr and Gly and thereafter covalently link the 608-
aa (68 kDa) remaining protein to the peptidoglycan layer. Using antibodies against the 
mature domain of the SesC protein, we were able to reduce S. epidermidis biofilm formation 
in vitro (Shahrooei et al. 2009). In addition, active and passive immunization against SesC 
could significantly reduce their biofilm formation on catheter fragments in animal models of 
subcutaneous and intravascular catheter infection (Shahrooei et al. 2009). However, the 
involvement and exact function of SesC in S. epidermidis biofilm formation have remained 
unknown, so far. In order to elucidate its role, knockout of sesC or isolation of S. 
epidermidis sesC-negative mutants were attempted, however without success. Therefore, as 
an alternative strategy sesC was introduced into S. aureus strains and the effect of sesC 
expression in biofilm formation by these host strains was studied. However, using this 
strategy, we should be careful with extrapolating conclusions in S. epidermidis, since they 
are different staphylococci. 
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5.2 Materials and Methods 
5.2.1 Bacterial strains, plasmids and media 
Cloning experiments were performed in Escherichia coli DH5α competent cells 
(Invitrogen). E. coli DH5α transformants were grown in Lysogeny Broth (LB) or on LB agar 
at 37°C supplemented with ampicillin (100 µg/), as all plasmids used in this study (Table 
5.1) contain an ampicillin resistance (bla) gene. All Staphylococcus strains (Table 5.1) were 
grown in brain heart infusion (BHI) medium or agar, and for biofilm formation assays also 
in BHI medium supplemented with 4% NaCl (BHI-NaCl) or 1% glucose (BHI-glucose). 
Bacterial CFU counting was done on Tryptone Soya agar (TSA, Oxoid) or blood agar plates 
(BD Biosciences). Whenever required, growth media were supplemented with appropriate 
antibiotics as follows: chloramphenicol at 10 µg/, erythromycin at 10 µg/ and tetracycline at 
5 µg/. Species identification and antibiograms for all clinical isolates were performed using 
a VITEK® 2 automated system (bioMérieux). 
Table 5.1. Staphylococcus strains and plasmids used in this study. 
Strains Characteristic(s) Reference 
- S. epidermidis   
10b Clinical isolate (Van Wijngaerden et al. 1999) 
- S. aureus   
RN4220 Restriction-negative derivative of 8325-4 (Kreiswirth BN, et al. 1983) 
8325-4  NCTC8325 cured of prophages. 11-bp deletion in 
rsbU. 
(Fitzpatrick et al. 2005) 
BH1CC  MRSA clinical isolate. Biofilm positive. SCCmec 
type II, ST type 8, clonal complex 8. 
(Fitzpatrick et al. 2005) 
MSSA4 Clinical isolate This study 
8325-4 ica::tet icaADBC::tet; isogenic mutant of 8325-4 (Fitzpatrick et al. 2005) 
8325-4 srtA::tet srtA::tet; isogenic mutant of 8325-4 (O’Neill et al. 2008) 
BH1CC ica::tet  icaADBC::tet; isogenic mutant of BH1CC (Fitzpatrick et al. 2005) 
BH1CC 
srtA::tet 
srtA::tet; isogenic mutant of  BH1CC (O’Neill et al. 2008) 
Plasmids   
pCN68 E. coli-Staphylococcus shuttle vector (Charpentier et al. 2004) 
pSRsrtA5 E. coli-Staphylococcus shuttle vector (O’Neill et al. 2008) 
pET11c E. coli vector (Stratagene, La Jolla, CA) 
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5.2.2 Producing polyclonal antibody against SesC 
5.2.2.1 Construction and purification of his-SesC protein 
A truncation of the sesC gene with a sequence coding for a C-terminal His6 tag and 
incorporated flanking NheI and BamHI (Table 5.2) sites, was designed and cloned in 
pET11C vector (Table 5.1) and transformed into E. coli BL21 (DE3). Protein was purified 
as described previously (Shahrooei et al. 2012). Briefly, E. coli BL2 pET11C-his-sesC was 
grown in 1 L Luria-Bertani (LB) broth with 100 µg/ ampicillin and 1 mM isopropyl-β-D-
thiogalactopyranoside (IPTG) at 37°C, overnight with shaking. To purify whole proteins, 
cells were harvested by centrifugation (4,000 rpm, 10 min, 4°C) and resuspended in 25  lysis 
buffer (PBS pH 7.5, 1 mM β-mercaptoethanol plus 1 tablet protease inhibitor Mini, EDTA-
free), French pressed and stirred in 4°C with adding DNaseI. To get rid of aggregation, we 
kept the proteins on ice and filtered them before use. 
Before the actual purification and sample injection into the AKTA, the His column was 
stripped, charged, and blanked. The purification was done by program in the AKTA Xpress. 
The purified proteins were collected from different tubes and the combined fractions were 
kept at 4 ºC. Since the buffer contained imidazole, the samples were dialyzed against PBS. 
5.2.2.2 Immunization of rabbits and producing polyclonal antibody against SesC 
Immunization was done during 10 days with two injections intraperitoneally. The first 
injection was administered with a mixture of SesC protein and Complete Freund’s adjuvant 
(CFA; Sigma), and a booster injection was performed after titration of the antibody (ELISA) 
with protein and Incomplete Freund’s adjuvant (IFA; Sigma) at day 10. Then from the 
serum, the total immunoglobulin Gs (IgGs) against rSesC (anti-rSesC) were purified by 
absorption to a protein G column (GE Healthcare) according to the manufacturer's 
instructions. 
5.2.3 Cloning and expression of S. epidermidis sesC and sesK genes in S. aureus 
strains 
The coding regions of S. epidermidis sesC (SE2232, Gene ID 1056520) and sesK (SE1501, 
Gene ID 1056680), were amplified using sesC- and sesK-specific primers (Table 5.2) 
containing additionally a SalI or SmaI restriction site for cloning purposes. Genomic DNA 
(gDNA) of biofilm-forming S. epidermidis strain 10b, a clinical isolate (Van Wijngaerden et 
al. 1999), was used as a template. The amplicons were ligated into SalI/SmaI-digested 
pCN68 E. coli - Staphylococcus shuttle vectors (Charpentier et al. 2004) yielding pCNsesC 
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and pCNsesK. In this plasmid, PblaZ is the promoter. It is a highly active constitutive 
promoter; erythromycin was used as the selection marker. All recombinant plasmids were 
replicated in E. coli DH5α. Correctness of cloning was confirmed by restriction enzyme 
digestion, PCR, and nucleotide sequence analysis of the insert. Plasmids harvested from E. 
coli were first electroporated into the restriction-deficient S. aureus strain RN4220 and 
subsequently into other S. aureus strains. Presence and expression of sesC, sesK, sasF (Gene 
ID: 5775591), and icaA (Gene ID: 5776135) in transformed strains were evaluated using 
gel-based reverse transcription-PCR (RT-PCR) and Western blotting assays. Plasmid, 
gDNA and RNA isolation from bacterial strains and cDNA synthesis were performed as 
previously described (Shahrooei et al. 2012). 
 
Table 5.2. Primers used in this study 
Name Sequence (5’ → 3’) RE site 
sesCFs sesCF ATGTCGACTTTATTAAAGGAGTATGTGTAAATG SalI 
sesCR ATCCCGGGTGATGATGCCTATTACTATATATAA SmaI 
sesKF ATGTCGACGACCTCTTAACTAATTATGTTATG SalI 
sesKR ATCCCGGGTCTCGTTATTTTCACTCAAATATC SmaI 
rsesc354Fwd ACGTGCTAGCGCAGATTCAGAAAGTACATC NheI 
rsesc354hisRev ATGCGGATCCTAGTGATGGTGATGGTGATGATCAGCTGTAGCTGTTCC  BamHI 
(Underlined sequences: restriction sites; bold sequence: start codon, blue His codons) 
5.2.4 Biofilm formation assay 
The amount of biofilm formed by the different strains was determined using a semi-
quantitative adherence assay in 96-well polystyrene microtiter plates (BD Biosciences) as 
previously described (Shahrooei et al. 2009; Shahrooei et al. 2012). Briefly, 20 µl of stock 
cultures were inoculated into 5  (selective) BHI medium and grown to the end-exponential 
growth phase in a shaking incubator at 37°C. Cultures were subsequently diluted to an 
OD600 of 0.005 (5x106 CFU/) in fresh BHI medium supplemented or not with 4% NaCl or 
1% glucose. 200 µl of the diluted cultures of bacteria were pipetted into sterile 96-well 
polystyrene microtiter plates and incubated overnight at 37°C without shaking. 
After incubation, the wells were rinsed 3 times with phosphate-buffered saline (PBS) and 
dried afterwards. The adhered material was stained with 200 µl of a 1% (w/v) crystal violet 
(Sigma) solution for 10 min, and subsequently, the wells were washed 3 times with water 
and again dried. For quantification, 160 µl of 30% (v/v) acetic acid solution was added to 
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each well to dissolve the crystal violet. The OD595 of the dissolved stain was measured in a 
multipurpose UV/VIS plate reader (VICTOR3 TM; PerkinElmer). 
5.2.5 Biofilm stability and inhibition assays 
The biofilm stability against sodium metaperiodate (SM), proteinase K (PK) or DNase I 
treatment was tested as described previously (O’Neill et al. 2008; Rohde et al. 2005; Kaplan 
2004). Briefly, 200 µl of an overnight grown culture diluted to an OD600 of 0.005 in BHI-
glucose, were pipetted into sterile 96-well polystyrene microtiter plates and statically 
incubated overnight at 37°C. After 24 h incubation, the growth medium was replaced with 
200 µl solution of SM (10 mM in 50 mM sodium acetate), of PK (Qiagen GmbH, 1 mg/ in 
100 mM NaCl, 20 mM Tris/HCl, pH 7.5) or of DNase I (Sigma, 2 mg/ in 5 mM MgCl2). 
Subsequently, plates were incubated at 37°C for 2 h and the remaining biofilms were 
quantified as explained above.  
To assess the effect of specific anti-SesC antibodies (αSesC-IgGs) produced as earlier 
described (Shahrooei et al. 2009) on biofilm formation, 1x106 bacteria were in the first 
instance incubated with αSesC-IgGs (20 µg/ bacterial suspension) for 2 h at 4°, and in a 
volume of 200 µl medium brought into a 96-well plate. Plates were incubated overnight at 
37°C without shaking to allow bacterial growth and biofilm formation.  
5.2.6 PIA quantification by PIA non-specific immunoblot assay 
The relative amount of PIA present in a biofilm was determined as described (Singh et al. 
2010), however with some modifications. Briefly, 1  of a diluted overnight culture of 
bacterial suspension (5x106 CFU/) in BHI-NaCl or BHI-glucose were pipetted in 24-well 
polystyrene microtiter plates (BD Biosciences) and next, plates were incubated overnight at 
37°C. After incubation, spent medium was removed, 500 µl PBS was added into each well 
and the biofilm mass was removed from the surface via pipetting. Samples were transferred 
to 1.5  tubes which were next centrifuged for 3 min at 12000×g. Pellets and biofilm material 
were re-suspended in 0.5 M EDTA (pH 8) to an OD600 of 0.5 and PIA was extracted by 
boiling the samples for 5 min. After centrifugation at 18000×g, 250 µl of the supernatant 
was added to an Eppendorf tube with 25 µl PK solution (20 mg/). The mixture was 
incubated for 1 h at 60°C and afterwards PK was deactivated for 30 min at 80°C. Sample 
aliquots were applied to a nitrocellulose membrane, which was blocked with 5 % (w/v) 
bovine serum albumin (BSA) in TTBS [Tris-buffered saline (100 mM Tris/HCl, 0.9% NaCl) 
with 0.05 % Tween 20]. After washing the membrane 3 times in TTBS, it was incubated 
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overnight at 4°C with wheat germ agglutinin-horseradish peroxidase conjugate (EY 
laboratories) in 1% (w/v) BSA-TTBS. After washing the membrane 3 times in TTBS, the 
presence of PIA was detected by the addition of Western blotting detection reagent 
(AmershamTM ECL, GE Healthcare), and visualized with a ChemiDoc™ XRS+ System 
(Bio-Rad).  
5.2.7 Detection of SesC  
Western blot analysis of SesC was performed as described (Hu et al. 2011). Cells of 10  
overnight bacterial cultures grown at 37°C in BHI-glucose were harvested by centrifugation, 
resuspended in lysis buffer [10 mM Tris/HCl, 10 mM EDTA, 1 mM phenylmethanesulfonyl 
fluoride (PMSF), pH 7.5, 100 µg lysozyme/, 100 µg lysostaphin/] and incubated for 1 h at 
37°C. Then, cells were broken by passing them three times through a French press at 69 
MPa (SLM Aminco) followed by sonication (Branson 2510, 42 kHz) of samples on ice. 
Proteins were electrophoretically separated on a 12% sodium dodecyl sulphate 
polyacrylamide gel and subsequently transferred onto a PVDF membrane. The primary 
antibody (1:5000 dilution of rabbit anti-SesC polyclonal antibodies in TTBS) was added to 
the membranes, which were left overnight, followed by horseradish peroxidase-conjugated 
anti-rabbit IgGs as secondary antibodies [1:2500 dilution in TTBS+1% (w/v) skim milk] for 
2 h. Finally, the presence of SesC was visualized using ECL Western blotting detection kit 
(GE Healthcare) in combination with a ChemiDoc™ XRS+ System (Bio-Rad). 
5.2.8 Scanning Electron Microscopy 
In vitro biofilm formation on cover Glasses (Ø 10 mm, Menzel GmbH) was visualized by 
scanning electron microscopy (SEM) as described (Pintens et al. 2008). Briefly, an 
overnight bacterial culture was diluted in BHI-glucose to an OD600 of 0.005, and 1  of the 
diluted culture was pipetted into the wells of sterile 24-well polystyrene microtiter plates, 
which each contained a glass disk. Plates were incubated overnight at 37°C without shaking, 
after which the disks were washed 3 times with PBS. Biofilms formed on the disks were 
fixed with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) by incubation 
for 2 h at room temperature. After fixation, disks were rinsed with 0.1 M sodium cacodylate 
buffer (pH 7.4) for 30 min with three changes. Thereafter, a post-fixation step was done with 
1% osmium tetroxide for 2 h at 4°C. Next, disks were rinsed with distilled water (2 times, 10 
min) and then dehydrated in 10 min steps in a series of ascending ethanol baths (25%, 50%, 
75%, 95% and 100%). Following a bath of hexamethyldisilazan, dehydrated air-dried 
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samples were mounted on support stubs with C-stickers and silver glue, and sputter coated 
with platinum (Agar Scientific, Auto Sputter Coater). Finally, the samples were observed 
and images taken with a JSM7401F field emission scanning electron microscope (JEOL) in 
a high vacuum mode with a conventional Everhart-Thornley detector at 5kV accelerating 
voltage. 
5.3 Results 
5.3.1 Heterologous expression of sesC in S. aureus switches the biofilm phenotype 
from PIA-dependent to proteinaceous 
The S. epidermidis sesC gene was cloned into a pCN plasmid resulting in pCNsesC. The 
recombinant plasmid was introduced into the laboratory S. aureus strain 8325-4, which 
makes a PIA-type biofilm, and into the hospital-associated MRSA strain BH1CC, which 
makes a eDNA and proteinaceous biofilm (AtlE/FnBP-dependent) (Houston et al. 2011; 
Pozzi et al. 2012). The expression of sesC and the presence of the corresponding protein 
were confirmed by gel-based RT-PCR assay and Western blot assay (Figures 5.1A and B). 
Western blot confirmed the expression of SesC in the transformant strains. Heterologous 
expression of sesC had no effect on the BH1CC biofilm phenotype (data not shown), but 
inhibited biofilm formation by S. aureus 8325-4 transformants cultivated in BHI-NaCl 
(Figures 5.1C and D). Furthermore, 8325-4 (pCNsesC) biofilms grown in BHI-glucose were 
dispersed with proteinase K (PK) but not sodium metaperiodate (SM), which did disperse 
wild-type S. aureus 8325-4 biofilms (Figures 5.1C and D). This is consistent with a biofilm 
phenotypic switch from PNAG- to protein-mediated in these transformants. Nevertheless, 
quantification of PIA showed no changes in the rate of PIA production in S. aureus 8325-4 
(pCNsesC) in comparison to the wild-type strain (Figure 5.1E). 
In order to confirm the relation between SesC production and a phenotypic switch of biofilm 
growth, another ica-positive, PIA-dependent biofilm-forming S. aureus strain, the clinical 
isolate MSSA4, was transformed with pCNsesC. As observed in 8325-4, the biofilm 
phenotype of MSSA4 switched from PIA-dependent to proteinaceous following introduction 
of pCNsesC (Figure 5.1F). 
Moreover, the effect of αSesC-IgGs on biofilm formation by S. aureus strains 8325-4 and 
8325-4 (pCNsesC) grown overnight in BHI-glucose was investigated. αSesC-IgGs had no 
effect on 8325-4 or 8325-4 carrying the empty plasmid, but inhibited biofilm formation by 
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8325-4 (pCNsesC) up to 80% (Figures 5.1C and D). Treatment with DNaseI did not have 
any significant impact on the biofilms (data not shown).  
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Figure 5.1. Effect of transformation of S. aureus strains with sesC or sesK on the biofilm 
formation. Using a semi-quantitative microtiter plate assay the level of biofilm formation in 
different media, the phenotype of biofilms and effect of αSesC-IgG antibodies on biofilm formation 
of different strains were identified. Biofilm formation in medium supplemented with NaCl or the 
effect of dispersal agents were used to discriminate the phenotype of biofilms. (A) Expression of 
sesC, sesK, sasF and icaA in cDNA of transformed strains was evaluated using the gel-based reverse 
transcription-PCR assay. (B) Detection of SesC production in S. epidermidis 10b, 8325-4, 8325-4 
(pCNsesC) and 8325-4 ica::tet (pCNsesC)  8325-4 srt::tet (pCNsesC) ) in soluble and insoluble 
fractions via Western blot assay. (C) The effect of S. aureus 8325-4 transformation with sesC. 
Introduction of a plasmid carrying sesC but not the mock plasmid changed the biofilm formation of 
transformants in BHI-NaCl and also the effects of PK and SM were opposite. (D) Microtiter plate 
assay demonstrating the effect of the inducers of biofilm formation (glucose and NaCl) and dispersal 
agents on biofilm formation of strains (E) quantification of PIA production using PIA non-specific 
immunoblot assay for biofilm in BHI-Glu. (F) Effect of transformation with sesK on the biofilm 
formation of strain 8325-4 and also the effect of sesC on the biofilm formation of strain MSSA4 in 
comparison with MRSA strain BH1CC. (SM: sodium metaperiodate, PK: proteinase K; error 
bars mean standard deviation) 
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Scanning electron microscopy (SEM) images from S. aureus 8325-4, 8325-4 with mock 
plasmid, 8325-4 (pCNsesC) and BH1CC biofilms, respectively, showed morphological 
differences (Figure 5.2). In BHI-glucose, S. aureus 8325-4 formed porous and less 
condensed biofilms whereas 8325-4 (pCNsesC) formed more condensed and smoother 
biofilms with a glue-like matrix as seen in BH1CC biofilms. S. aureus 8325-4 ica::tet did 
not form biofilm whereas 8325-4 ica::tet (pCNsesC) presented as a biofilm forming strain 
(Figure 5.2). To evaluate whether the phenomenon of biofilm phenotypic switching is due to 
the specific function of SesC or to high-level constitutive production of any LPxTG surface 
protein, the sesC gene in pCNsesC was replaced with sesK that encodes another LPxTG 
protein in S. epidermidis. Unlike sesC, which is present in all S. epidermidis strains, sesK is 
only present in circa 10% of S. epidermidis isolates (Shahrooei et al. 2012). Additionally, it 
was previously shown that anti-SesC antibodies could reduce S. epidermidis biofilm 
formation, whereas anti-SesK antibodies had no effect (Shahrooei et al. 2012). 
Transformation with pCNsesK had no impact on the biofilm phenotype of S. aureus 8325-4 
(Figure 5.1F), showing that the effect of heterologous expression of sesC in PIA-producing 
S. aureus may be specific. 
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Figure 5.2. SEM images of biofilms formed by S. aureus 8325-4 and 8325-4 ica, their sesC-
expressing transformants and BH1CC as controls. Biofilm growth on glass disks was allowed 
during overnight incubation at 37°C in BHI supplemented with 1% glucose. The next day, samples 
were fixed and sputter coated with platinum. The images show bacteria attached on the surface of 
disks at 1000x, 15000x magnification. 
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5.3.2 Expression of sesC promotes biofilm production by an ica mutant of S. aureus 
8325-4 
Previously published data revealed that deletion of the ica operon encoding PIA 
biosynthesis impaired PIA-dependent biofilm production by S. aureus 8325-4 but had no 
impact on the biofilm formation by MRSA strain BH1CC which expresses an AtlE/FnBP-
mediated biofilm phenotype (Houston et al. 2011). Transformation of S. aureus 8325-4 
ica::tet with sesC - in contrast to sesK - restored the biofilm formation to approximately 
wild-type levels in BHI-glucose (Figure 5.3). Furthermore, SEM analysis showed that the 
morphology of S. aureus 8325-4 ica::tet (pCNsesC) biofilms was similar to 8325-4 
(pCNsesC) biofilm (Figure 5.2). Interestingly, when grown in medium supplemented with 
NaCl, which induces a PIA-type biofilm, S. aureus 8325-4 ica::tet (pCNsesC) was unable to 
produce biofilm while in BHI-glucose biofilm growth of 8325-4 ica::tet (pCNsesC) 
occurred. In addition, these biofilms were dispersed by PK, indicating a proteinaceous 
biofilm phenotype for this transformed mutant (Figure 5.3). 
 
Figure 5.3. Effect of transformation with sesC and sesK on biofilm formation by non-biofilm-
forming S. aureus 8325 ica::tet mutant. Transformation of this non-biofilm-forming mutant with 
sesC restored its biofilm formation and converted it to protein-mediated biofilm-forming strain that 
cannot form biofilm in the presence of NaCl and is dispersed by PK but not SM. Transformation 
with sesK had no effect. Mutation of the ica in PIA-independent biofilm-forming BH1CC strain had 
no effect on its biofilm formation.  
(SM: sodium metaperiodate, PK: proteinase K; error bars mean standard deviation) 
5.3.3 Surface expression of SesC is involved in biofilm formation 
LPxTG proteins are known to be anchored to the bacterial peptidoglycan by sortases 
(Marraffini et al. 2006; Dramsi et al. 2005; Dramsi et al. 2008). Deletion of srtA inhibits 
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LPxTG protein-dependent biofilm formation. In 2008, O'Neill et al. reported that deletion of 
srtA in BH1CC impairs its biofilm forming activity, while biofilm formation of S. aureus 
8325-4 srtA::tet was not affected (O’Neill et al. 2008). Introduction of pCNsesC in the latter 
strain, however, completely impaired biofilm production, further indicating the dominant 
role of SesC over PIA-type biofilm production (Figure 5.4). Unlike 8325-4, in the absence 
of sortase the S. aureus 8325-4 srtA::tet (pCNsesC) strain was unable to form biofilm. The 
presence of SesC in the soluble and insoluble proteins fractions of the transformant strain 
was investigated and showed that in the S. aureus 8325-4 srtA::tet (pCNsesC) SesC is only 
expressed in the soluble fraction (Figure 5.1B). This strongly suggests that presence of srt is 
necessary for sorting SesC to the cell wall. 
 Complementation of S. aureus 8325-4 srtA:: tet (pCNsesC) with the plasmid pSRsrtA5 
carrying the S. aureus srtA gene (O’Neill et al. 2008) restored biofilm formation (Figure 
5.4). The biofilm of this complemented strain was only induced in BHI-glucose 1%, not in 
BHI-NaCl, and dispersed only with Proteinase K and not with sodium metaperiodate.  
 
Figure 5.4. Effect of transformation with sesC on biofilm formation by the biofilm-forming 
isogenic srtA mutants of 8325-4. Effect of srtA mutation on biofilm formation of PIA-dependent 
biofilm-forming S. aureus 8325-4, (Atl/FnBP)-mediated biofilm-forming strain BH1CC, the sesC-
tranformed 8325-4 srtA::tet strain and complementation of S. aureus 8325-4 srtA::tet (pCNsesC) 
with srtA, was evaluated using the quantitative microtiter plate assay. (SM: sodium metaperiodate, 
PK: proteinase K; error bars mean standard deviation) 
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5.4 Discussion 
Surface proteins have been shown to play important roles in S. epidermidis and S. aureus 
biofilm formation, especially by MRSE and MRSA in device-related infections (Hennig et 
al. 2007; Houston et al. 2011; Mack et al. 2007). We previously reported that rabbit 
polyclonal antibodies directed against the extracellular domain of S. epidermidis LPxTG 
surface protein SesC (or αSesC-IgGs) can significantly inhibit S. epidermidis biofilm 
formation in vitro and in vivo in a rat model of subcutaneous CRI as well as in a mouse 
model of jugular vein CRI (Shahrooei et al. 2012). It has also been demonstrated that active 
immunization with the recombinantly produced extracellular domain of SesC decreased S. 
epidermidis biofilm formation in a rat model of subcutaneous CRI (Shahrooei et al. 2012). 
Data obtained in this study are consistent with previous observations and demonstrate that 
SesC plays an important role in biofilm formation even in another genetic background.  
We have tried, but were unable to knock out sesC. It may be that knockout of sesC is 
associated with a lethal phenotype in these bacteria. On the other hand, using antisense 
RNAs to knock down sesC in S. epidermidis and subsequently applying gel-based reverse 
transcription-PCR (RT-PCR) assay and Western blot analysis, we could not see any changes 
in sesC expression in the transformed strain compared with the parental strain. 
PCR screening to determine the incidence of sesC in 300 clinical isolates of Staphylococcus 
spp. including 175 S. epidermidis, 33 isolates of methicillin-resistant S. aureus (MRSA), 50 
isolates of methicillin-sensitive S. aureus (MSSA) and 42 strains belonging to various non-
epidermidis CoNS species, revealed that sesC is present in all S. epidermidis strains, but not 
in other staphylococci, indicating that it is potentially a conserved, S. epidermidis-specific 
gene (Khodaparast et al. 2016a). 
Despite the lack of S. epidermidis sesC mutants, the unraveling of the function of SesC in 
biofilm formation was attempted by introduction of sesC into S. aureus strains that formed 
different types of biofilm (PIA-dependent, PIA-independent or non-biofilm-forming). Using 
gel-based RT-PCR assay and Western blot analysis, we confirmed sesC expression and the 
production of the corresponding protein in these transformed strains. Our findings revealed 
that transformation with sesC had no impact on the strains, which display proteinaceous 
biofilm phenotypes, while it caused a switch from PIA-dependent biofilm-formation to a 
proteinaceous-type biofilm in MSSA strains 8325-4 and MSSA4. As this biofilm phenotype 
switching was not associated with transformation of S. aureus 8325-4 with sesK, it can be 
concluded that the switch is not necessarily associated with high expression level of any 
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LPxTG surface protein or with the genetic background of the transformed strain, but is 
specifically caused by SesC. Results obtained also show that presence of SesC is dominant 
over the presence of PIA and impairs the role of PIA in cell-cell interaction. 
To further confirm the direct involvement of SesC in biofilm formation, we transformed the 
non-biofilm-forming, isogenic ica mutant of S. aureus 8325-4 (being 8325-4 ica::tet) with 
sesC. Transformation with sesC converted this non-biofilm-forming mutant to a 
proteinaceous biofilm-forming strain similar to its parental strain transformed with sesC. 
These data suggest a direct role for SesC in biofilm formation, because even in the absence 
of PIA we have the same effect of SesC on biofilm formation. 
To answer the question whether SesC affects PIA biofilm formation in mutated srtA strain, 
S. aureus 8325-4 srtA::tet was transformed with sesC.	Deletion of srtA has no impact on 
biofilm formation of PIA-dependent biofilm-forming strain 8325-4, but impairs the normal 
display of LPxTG surface proteins, including SesC. After the introduction of sesC, we 
observed that this biofilm-forming strain converted to a non-biofilm-forming strain. To 
confirm the localization of SesC in 8325-4 srtA::tet (pCNsesC) strain, we checked the 
presence of SesC in the soluble and insoluble protein fraction. Since SesC is a cell wall-
anchored LPxTG protein, basically we expected to find it in the insoluble fraction. However, 
SesC was observed only in the soluble part. These data suggest that the presence of sortase 
is necessary to sort SesC to the cell wall (Seddon et al. 2004).  
 Complementation of the non-biofilm-forming sesC-expressing mutant with srtA by means 
of transformation with pSRsrtA5 converted it to a proteinaceous biofilm-forming strain. 
These data confirm that transformation with sesC is sufficient to switch the mechanism of 
biofilm formation to a proteinaceous type biofilm on condition that SesC is sorted to its 
place on the surface, attached to the peptidoglycan layer. Our data show that SesC 
expression does not have any negative effect on PIA production. There is some evidence 
that may explain this phenomenon. Previous groups reported that the generation of PIA is 
not sufficient to form biofilm (Vergara-Irigaray et al. 2009). Vergara-Irigaray et al. showed 
that the clinical MRSA strain 132 is able to alternate between a proteinaceous and a 
polysaccharidic biofilm matrix, depending on environmental conditions, and strain S115 
generates PIA but is a non-biofilm-forming strain. This might be because of the existence of 
a defect in the export of PIA by IcaC or IcaB (Vergara-Irigaray et al. 2009). Similarly to the 
effect of FnAB on biofilm phenotype in S. aureus strain S132 and BH1CC, there is the 
possibility that here, the extracellular location of SesC changes the architecture of the cell 
wall to the extent that PIA can no longer link the cells. This hypothesis is consistent with the 
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observed effect of biofilm dispersal agents on sesC- and ica-positive strains. The 
observation that high level expression of another surface protein (SesK) did not have a 
similar effect may suggest some form of interaction between SesC and PIA that is absent for 
SesK. Different expression levels of SesC and SesK in spite of using the same expression 
vectors may offer another explanation. 
Expression of SasG, a surface protein in S. aureus, can similarly as SesC switch the biofilm 
of PIA-dependent S. aureus strains SH1000 and 8325-4 to protein-mediated biofilm 
(Corrigan et al. 2007) SasG like SesC is a fibrinogen-binding protein, and SasG masked 
binding to fibrinogen mediated by both ClfB and the FnBPs. Biofilm formation by SasG is 
also likely to be protease dependent, because the broad spectrum protease inhibitor a2-
macroglobulin inhibited the biofilm formation process of the strain SH1000 transformed 
with sasG (Corrigan et al. 2007). By looking at the protein sequences alignment of SesC and 
SasG, we realized they have 26% identity. 
Similar to the presented observations, a recent report illustrated the impact of introducing the 
methicillin resistance gene mecA into the PNAG-producing MSSA strain 8325-4 (Pozzi et 
al. 2012). This generated a heterogeneously oxacillin resistant (HeR) strain, from which a 
homogeneous, high-level resistant (HoR) derivative was isolated following exposure to 
oxacillin. Transcription of icaADBC and production of PNAG were impaired in the 8325-4 
HoR derivative, which instead produced a proteinaceous biofilm that was significantly 
inhibited by antibodies against the mecA-encoded penicillin binding protein 2a (PBP2a). 
HoR derivatives of S. aureus 8325-4 icaADBC::tet, 8325-4 fnbAB::tet, 8325-4 atl::cat and 
8325-4 srtA::tet exhibited a similar biofilm phenotype as 8325-4 HoR (Pozzi et al. 2012; 
McCarthy et al. 2015).  
SEM images confirm the presence of a morphologically different biofilm for S. aureus 
8325-4 in comparison to its transformant harboring pCNsesC. These findings are also 
supported by the effect of αSesC-IgGs on established biofilms of SesC-producing 
transformants. 
The obtained in vivo data (chapter 6) are consistent with our previous findings in suggesting 
an important role for SesC in infection. Transformation with sesC increased the organ 
infection rate up to 100-fold. This can be partially explained by the fact that fibrinogen is 
one of the components of the extracellular matrix (Pereira et al. 2002). Our previous report 
showed that transformation of S. aureus strain RN4220 with sesC increased the fibrinogen-
binding ability of transformants, suggesting SesC as a potential Fg-binding MSCRAMM 
(Shahrooei et al. 2009). But, our experiments also show enhanced adherence of the 
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transformant strains to an uncoated catheter in vitro, suggesting that the adherence effects 
are not entirely or solely mediated by binding to host factors. 
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6.1 Introduction 
S. epidermidis is a ubiquitous commensal and a part of the normal human flora, but they can 
easily attach to implanted devices and form biofilm (Ziebuhr et al. 2006). Medical device-
related infections are typified by high morbidity, and often require device removal (Hanke & 
Kielian 2012). 
Thus far, a subcutaneous rat model for CRIs was used (Shahrooei et al. 2009). Despite 
resembling intra-operative contamination with skin flora, this model does not mimic 
conditions found in the human intravascular system and has some limitations. The immune 
response at the site of infection in the subcutaneous model may not reflect the response to 
the intravascular device-related infections in the peripheral blood. Hence, this study was 
designed to develop an animal model for central venous catheter infections. This new model 
will be used in the future to evaluate the potential of vaccines and immunotherapy directed 
against S. epidermidis infections. This mouse model closely mimics the clinical situation of 
human infection (Parienti et al. 2015; Chauhan et al. 2016). 
6.2 Materials and Methods 
6.2.1 Jugular vein catheterized (JVC) mouse model 
Materials used during the surgery are listed in Figure 6.1 (Shahrooei et al. 2012; 
Khodaparast et al. 2016b). Briefly, 4-weeks-old female Swiss-Webster mice (Taconic) were 
anesthetized with a single intraperitoneal (i.p.) injection of sodium pentobarbital (Nembutal, 
40-60mg/kg body wt) and placed on a heating pad to maintain the body temperature at 37°C. 
An anesthetized and surgically prepared animal was then placed in dorsal recumbence under 
a dissecting microscope (Zeiss, Jena, Germany, 10x magnification). A small vertical incision 
was made using small scissors and the right jugular vein was identified, mobilized and 
exposed with blunt surgical dissection. A single lumen polyethylene catheter (internal X 
0.011 inch (0.28 mm); outer X 0.024 inch (0.61 mm); insertion length, 1 cm; Intramedic, 
Becton Dickinson and Company, cat. no. 427400) was inserted into the right jugular vein 
and advanced into the superior vena cava via a small incision in the vein made with vein 
scissors (Figure 6.2). A ligature was then tied loosely around the catheter and patency was 
verified. Once blood flow had been established, the catheter was anchored in place. 
Subsequently, a small midline skin incision was made between the scapulae. The catheter 
was subcutaneously tunneled by a straight surgical clamp and exteriorized through midline 
scapular incision. The incisions were then closed with stitches. The patency was tested and 
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the catheter was flushed with 100 µl of saline, sealed with a plug and left in place throughout 
the experiment. Thereafter, mice were housed separately and monitored for recovery (Figure 
6.2). 24 h after surgery, the mice were inoculated via the catheter lumen with 100 µl of an S. 
aureus suspension (OD600=0.03, containing ≈3x107 CFU). Then the catheter was flushed 
again with 100 µl saline so that bacteria entered the venous system of animals.  
 
Figure 6.1 Materials for surgery. A. Swiss mouse B. insulin syringe C. Nembutal D. Suture Threat 
E. small surgical scissors F. 2 Halstead Surgical Clamp G. small Mouse Catheter H. Sterile Surgical 
Silk Suture I. 0.9 NaCl solution J. surgical microscope K. Microsurgery-Forceps-Small L. Curved-
tipped microsurgery forceps, M. surgical tape N. Critoseal  
 
After taking the blood samples at day 1 or 5 post-infection, animals were euthanized 
by CO2 inhalation and catheters and organs (spleen, liver, heart, vein and right kidney) were 
aseptically harvested from euthanized animals. The harvested organs were mechanically 
homogenized in saline. The portion (~1 cm) of catheter that was inside the vein was cut 
gently, washed and placed in a tube containing 1  saline. Tubes containing the catheter 
fragments were vortexed for 10 s, sonicated for 5 min at 40 kHz in a water bath (Branson 
2200, Branson Ultrasonics) and again vortexed for 10 s. Serial dilutions of the organ 
homogenates and catheter fluid collections were cultured on blood agar plates using a spiral 
plating system, and plates were incubated at 37°C overnight. Colonies on all plates were 
counted and the number of bacteria was defined as the mean of at least 5 quantitative 
cultures. All in vivo experiments were repeated at least twice and conducted in compliance 
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with the guidelines for animal experimentation. The Institutional Animal Care Commission 
and Ethical Committee of the KU Leuven approved all experimental protocols. 
 
 
 
 
	
Figure 6.2. Jugular vein catheterization in mice 1. An anesthetized and surgically prepared animal 
was placed in dorsal recumbence under a dissecting microscope, 2.	A small vertical incision was 
made using small scissors and the right jugular vein was identified, 3&4. A single lumen 
polyethylene catheter, 1 cm, was inserted into the right jugular vein and advanced into the superior 
vena cava via a small incision in the vein made by vein scissors, 5. Once blood flow had been 
established, the catheter was anchored in place and the patency was verified, 6. A small midline skin 
incision was made between the scapulae, 7& 8. The catheter was subcutaneously tunneled by a 
straight surgical clamp and exteriorized through midline scapular incision. 9, 10& 11. The incisions 
were closed with stitches, 12. 24 h after surgery.  
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6.2.2 Investigation of the effect of SesC on the in vitro attachment to a catheter 
surface 
In vitro bacterial attachment to the surface of a commercial polyurethane (PU) intravenous 
catheter (Arrow International) was examined as described (Pintens et al. 2008) with some 
modifications. Overnight cultures of S. aureus strains 8325-4 and 8325-4 (pCNsesC) were 
washed with saline (0.9 % NaCl) and diluted to an OD600 of 0.03 in saline. Seven mm 
catheter fragments were added to 2  of bacterial suspension and the mixture was incubated at 
37°C. After 2 h incubation, catheters were removed. After gentle rinsing with saline, 
catheters were placed in a tube containing 1  saline. Tubes were vortexed for 10 s, sonicated 
for 10 min at 40 kHz using a Branson water bath and again vortexed for 10 s. Thereafter, 
tube contents were 10-fold serially diluted and 50 µl aliquots of each dilution were plated on 
TSA plates using a spiral plater system (Spiral Plater Systems, Inc. Cincinnati, Ohio), and 
plates were incubated at 37°C overnight. Colonies were counted and the number of bacteria 
was defined as the mean of at least five quantitative cultures. 
 
6.2.3 The effect of rabbit polyclonal αSesC-IgGs on S. epidermidis infection in the 
JVC model 
For this experiment, an overnight culture of S. epidermidis strain 10b, grown to the late 
exponential/stationary growth phase in BHI, was pelleted, resuspended, and diluted to an 
OD600 of 0.3 (~3x108) in 0.9% NaCl. Three inoculums were taken, one without any IgG, 
while two others were mixed with either preimmune or αSesC-IgGs (80 µg/) and incubated 
for 2 h at 4°C. After a 24-h recovery from surgery, 150 µl (~5x107 CFU) of the mixture was 
injected through the catheter lumen. Animals in the first, second and third groups received 
bacteria, bacteria preincubated with preimmune IgGs, and bacteria preincubated with 
αSesC-IgGs, respectively. After the blood samples were obtained at day 5 post-infection, the 
animals were sacrificed. The catheters were aseptically removed, and the portion (1 cm) that 
was inside the vein was cut, gently washed, and processed for quantitative culturing as 
explained above. To compare the overall infection rate, the spleens, livers, hearts, veins, and 
right kidneys were aseptically harvested, mechanically homogenized in 0.9% NaCl, and 
processed for quantitative cultures as explained above. 
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6.2.4  The study of the involvement of sesC in virulence and biofilm formation 
Nine mice were divided into 3 groups of 3 mice. Overnight cultures of S. aureus strains 
8325-4, 8325-4 (pCN68) and 8325-4 (pCN68sesC) grown to the late exponential/ stationary 
growth phase in (selective) BHI medium, were pelleted, re-suspended and diluted to an 
OD600 of 0.03 in 0.9% NaCl with the suitable antibiotics. After a 24 h recovery period, 
animals in one group were inoculated through the catheter lumen with 100 µl of one of 3 the 
bacterial suspensions (~3x107 CFU) again with suitable antibiotics. Five days post-infection, 
the infection rate and the bacterial load on the implanted catheter were determined and 
compared between the 3 groups. 
 
6.3 Results 
6.3.1 The effect of αSesC-IgGs on the overall infection rate by S. epidermidis 
To investigate the effect of αSesC-IgGs antibodies in vivo, the mean numbers of bacteria 
recovered from the blood, catheters, veins, livers, spleens, hearts, and kidneys of animals in 
different groups were compared. Pre-incubation of bacteria with αSesC-IgGs significantly 
reduced the number of bacteria recovered from the catheter, vein, spleen, heart, liver, and 
kidney by 26-, 71.5-, 331-, 327-, 215-, and 52-fold, respectively (P<0.01, one-way 
ANOVA), whereas pre-incubation of bacteria with pre-immune IgGs had no effect on the 
infection rates (Figure 6.3). Almost no bacteria were found in the circulation (Shahrooei et 
al. 2012). 
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Figure 6.3. Effect of pre-incubation of S. epidermidis strain 10b with pre-immune or αSesC-IgGs 
on the overall infection rates in the JVC mouse model. A single lumen polyethylene catheter was 
surgically inserted into the right jugular vein of Swiss-Webster mice. After 24 h, an overnight culture 
of S. epidermidis strain 10b (~3x108+) in 0.9% NaCl was mixed with pre-immune or αSesC-IgGs 
(80 µg/) or the same volume of PBS, followed by incubation for 2 h at 4°C. After a 24-h recovery 
from surgery, 150 µl(~5x107) of the mixture was injected through the catheter lumen. After 5 days, 
the overall infection rates in different organs and the catheter colonization were quantified. Data for 
each group were obtained from bacteria recovered from the catheter or organs of six infected mice 
(three mice per group in each experiment, three groups, two independent experiments). The error 
bars indicate the standard errors of the mean (Shahrooei et al. 2012).	
6.3.2 Heterologous expression of sesC increases colonization of polyurethane 
intravenous catheters in vitro and in vivo 
Transformation of S. aureus 8325-4 with sesC significantly increased its attachment to 
polyurethane intravenous catheters in vitro (P<0.01; 1-way ANOVA) (Figure 6.4 A). Using 
a jugular vein catheterized (JVC) mouse model, the number of bacteria recovered from the 
catheter implanted in animals and afterwards infected with S. aureus 8325-4 (pCNsesC) was 
also significantly higher than after administration of S. aureus 8325-4 (P<0.05; 1-way 
ANOVA) (Figure 6.4 B). Interestingly, 8325-4 (pCNsesC) did not only show an increased 
catheter colonization ability compared to the non-transformed strain, but also the overall 
infection rate was raised. The number of 8325-4 versus 8325-4 (pCNsesC) cells in blood 
were similar, but the number of S. aureus 8325-4 (pCNsesC) cells recovered from organs 
such as spleen, liver, heart, vein and kidney were significantly increased compared to S. 
aureus 8325-4 (10- to 100-fold, P<0.05; 1-way ANOVA) (Figure 6.4 B). These results 
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indicate that SesC is a colonization factor that may promote S. epidermidis catheter and 
organ colonization, which in turn is the first step in biofilm formation and the establishment 
of a chronic infection.  
 
Figure 6.4. Effect of transformation with sesC on in vitro and in vivo catheter colonization and 
in vivo organ colonization. (A) Seven mm catheter fragments were inoculated with S. aureus 8325-
4 or its sesC-expressing transformant. After 2 h incubation at 37°C, catheters were rinsed and 
adherent bacteria were detached by sonication and the numbers of bacteria recovered from each 
catheter fragment were quantified by quantitative cultures. (B) In vivo, catheterized animals were 
inoculated through the catheter lumen with S. aureus 8325-4 strain or its 8325-4 (pCNsesC) 
transformant. At day 5 post-infection, the numbers of bacteria attached to the catheters or recovered 
from organs were quantified by quantitative cultures. The sesC-expressing transformant 8325-4, 
(pCNsesC) has a higher rate of colonization of different organs up to 100-fold compared to its 
parental strain. *: P<0.05 
6.3.3 Antibodies against SesC have a therapeutic effect in a S. aureus strain 8325-4 
(pCNsesC)-induced catheter-related infection 
The rate of catheter and organ colonization significantly decreased (100-100.000 fold; 
P<0.01-0.001; 1-way ANOVA) in the JVC mouse model group inoculated with 8325-4 
(pCNsesC), which was pre-incubated with αSesC-IgGs versus untreated 8325-4 (pCNsesC) 
(Figure 6.5). Pre-immune IgGs had no significant effect on the catheter and organ 
colonization by S. aureus 8325-4 or its sesC-expressing transformant (data not shown). 
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Figure 6.5 Effect of αSesC-IgGs on catheter colonization and infection rate by 8325-4 and its 
sesC-expressing transformant. Catheterized animals were inoculated with bacteria pre-incubated 
with αSesC-IgGs or pre-immune IgGs for 2 h at 4°C. The next day, animals were sacrificed and the 
bacteria were recovered from the catheter and organs and quantified by quantitative cultures. Pre-
incubation with αSesC-IgGs significantly reduced the rate of catheter and organ colonization by 
8325-4 (pCNsesC) from 10 to 10000-fold. *p<0.05 
6.4 Discussion and Conclusion  
The immune response at the site of infection in the subcutaneous rat model that we have 
used so far may not completely reflect the immune response to the intravascular device-
related infections in peripheral blood. In this study, we developed and used a mouse JVC 
model to investigate the effect of anti-sesC antibodies. The transformant strains with sesC 
showed a significantly better attachment to the catheter in comparison to the parental strains. 
This higher colonization suggests a role for SesC in attachment to the catheter surfaces. 
Reduction of in vivo catheter and organ colonization by SesC-producing S. aureus strains in 
the presence of αSesC-IgGs indicate the specificity of the antibody, surface expression of 
SesC, and involvement of SesC in catheter and organ colonization (Khodaparast et al. 
2016b). 
Although, we have to be cautious in extrapolating conclusions based on data obtained in S. 
aureus to S. epidermidis, we conclude that SesC is a virulence factor associated with the 
early stages in S. epidermidis biofilm formation, such as adhesion and colonization. This 
way SesC may favor chronic, persistent infections on indwelling biomaterials. The biofilm 
formation abilities of S. epidermidis may be due in part to the presence of SesC and similar 
factors (Khodaparast et al. 2016b).	
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The experiments described in the following chapter were carried out by L. Khodaparast and 
published as a part of the paper of Shahrooei et al. 2012 (Infect Immun. 2012 
Oct;80(10):3660-8. doi: 10.1128/IAI.00104-12. Epub 2012 Jul 16). 
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7.1 Introduction 
The OpsonoPhagocytic Killing (OPK) assay is one of the assays used to measure the 
functional capacities of vaccine-candidate-raised antibodies. This in vitro assay can help to 
demonstrate if the vaccine-induced antibodies drive efficient complement deposition and 
subsequent opsonophagocytic killing (Boackle 1993). It has been already shown that among 
five potential surface-exposed “Ses” proteins of S. epidermidis, SesC is the most 
immunogenic protein (Shahrooei et al. 2012). To understand the immunological effector 
function of specific rabbit polyclonal anti-SesC IgGs, we performed an in vitro 
opsonophagocytosis assay. 
7.2 Materials and Methods 
7.2.1 Neutralizing antibody assays 
In this study, a neutralizing antibody assay was done to check whether the polyclonal 
antibody against SesC has a neutralizing effect. To this purpose, we compared the rate of 
growing of S. epidermidis with or without this antibody. 
This experiment was done on two S. epidermidis strains with different mechanism of biofilm 
(1457, PIA dependent and eDNA, and st8, a clinical isolate with proteinaceous biofilm). 
Briefly, the overnight cultures were diluted to the OD600=0.001 in BHI medium. At  several 
time points, including 0’, 30’, 1 h, 2 h, …, 10 h,  the OD in the presence or absence of anti-
SesC-IgGs (30 ug/) was checked.  
7.2.2 Opsonophagocytosis assay 
 To prepare the bacteria for the evaluation of susceptibility to opsonic killing, cells 
from an overnight culture of S. epidermidis 10b in BHI were pelleted for 5 min at 12,000 g 
at 4°C, washed twice with PBS, and subsequently diluted to an OD600 of 1. For evaluation of 
opsonophagocytosis of planktonic cells, 10 µlof bacterial suspension was used, and for 
evaluation of opsonophagocytosis of biofilm cells, 5-mm catheter (Arrow International) 
fragments were added to the bacterial suspension, incubated at 37°C for 2 h, and 
subsequently washed with 1  of PBS. The opsonophagocytosis assay was performed with 
fresh blood obtained from human healthy volunteers as previously described (Smith et al. 
2012), with some modifications. Briefly, fresh whole blood from two volunteers was 
collected in vacuum blood collection tubes containing the anticoagulant heparin and then 
aliquoted into 1.5- microcentrifuge tubes (0.5 /tube). Catheter fragments pre-incubated with 
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S. epidermidis strain 10b or planktonic bacteria (10 µlof bacterial suspension with an OD600 
of 1) after 1 h pre-incubation at 4°C with pre-immune or anti-SesC-IgGs (30 ug/) or the 
same volume of PBS, or nothing, were added to the 1.5-ml microcentrifuge tubes containing 
0.5 ml of fresh blood. Tubes were incubated at room temperature with gentle rocking and, 
after 30 min, the samples containing planktonic bacteria were serially diluted and plated 
onto TSA plates to determine the number of surviving CFU. For samples containing catheter 
fragments, catheter fragments were first removed and gently washed with 1 ml of saline and 
then processed for quantification of the number of surviving cells on the catheter fragments 
as explained in chapter VI. In order to determine the input CFU in samples containing 
planktonic or sessile bacteria attached to the catheter fragments, a portion of untreated 
planktonic samples was serially diluted and plated onto TSA plates, or the number of 
bacteria attached to the untreated catheter fragments was quantified as explained above. All 
samples were assayed in triplicate, and all experiments were repeated at least twice 
(Shahrooei et al. 2012). 
7.3 Results 
7.3.1 Polyclonal antibody against SesC does not have a neutralizing effect 
In this experiment, the rate of growing of bacteria in different time points in the presence or 
absence of antibody was checked. The results showed no changes in the growing of these 
bacteria in presence of antibody (Figure 7.1). This suggests that this antibody has no 
neutralizing effect. 
 
Figure 7.1. Neutralizing effect of anti-SesC-IgGs on S. epidermidis growth. The growth rates of 
planktonic bacteria (starting OD600=0.001) were checked in presence of anti-SesC-IgGs. These 
results are the average of three different biological repeats.  
0	0.2	
0.4	0.6	
0.8	1	
1.2	1.4	
1.6	
0	 2	 4	 6	 8	 10	 12	 14	
O
D
60
0=
0.
00
1	
Time/hour	
S.	e1457	
S.	e1457treated	anti-SesC	
S.	e	st8	
S.	e	st8	treated	anti-SesC	
	CHAPTER	VII:	Opsonophagocytosis	of	planktonic	and	sessile	bacteria	by	αSesC-IgG’s	
	 73	
7.3.2 αSesC-IgG antibodies has a opsonic effect 
Incubation of bacteria in the planktonic or sessile state with whole blood for 30 min led to a 
significant reduction (>1 log10) in PBS-treated versus untreated bacteria (P<0.001) (Figure 
7.2). Pre-incubation of bacteria in both planktonic and sessile forms with αSesC-IgGs 
significantly enhanced the opsonophagocytic killing of bacteria (P<0.001, one-way 
ANOVA) compared to bacteria treated with pre-immune IgGs or PBS (Figure 7.2). There 
was no difference between bacteria treated with pre-immune IgGs and PBS. αSesC-IgGs 
showed the same level of enhancement of opsonophagocytic killing of bacteria for both 
planktonic and sessile bacteria (Shahrooei et al. 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2. Effect of pre-incubation of S. epidermidis strain 10b with αSesC-IgGs on phagocytosis 
of planktonic and sessile bacteria by human neutrophils. Bacteria grown in planktonic form or 
attached to catheter fragments were tested for their ability to survive in human blood after pre-
incubation with pre-immune IgGs or αSesC-IgGs. Surviving bacteria were measured by viable 
counting. The data are presented as the mean log10 of surviving CFU. The data for each group are 
the average of six measurements in two independent experiments. The error bars represent the 
standard deviation of the measurements. 
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7.4 Discussion and Conclusion 
The primary functions of antibodies are, to a lesser extent, neutralization and more 
importantly, opsonization. The difference between a neutralizing antibody and a binding 
antibody is that neutralizing antibodies neutralize the biological impact of the antigen, while 
binding antibodies mark antigens to the white blood cell. Since the αSesC-IgGs don’t have 
any effect on the growth of the bacteria, a neutralizing effect seems less likely. 
The effect of αSesC-IgGs on S. epidermidis biofilms in vitro, in the absence of immune 
system components, suggested a neutralizing effect of αSesC-IgGs or blocking of the 
function of SesC. However, in vivo, in addition to neutralization, antibodies can opsonize 
their ligand, thus facilitating its uptake and destruction by natural killer cells, activating 
complement, and enhancing phagocytosis. The effect of αSesC-IgG antibodies on 
opsonophagocytosis of planktonic cells in vitro indicates their potential opsonic activity, 
whereas the reduction of the number of sessile bacteria on catheters in this experiment can 
be due to both neutralization and the opsonic activity of αSesC-IgGs. It is also possible that 
binding by αSesC-IgG to SesC on the surface of sessile bacteria triggers their detachment 
from catheter fragments and subsequent phagocytosis by neutrophils (Shahrooei et al., 
2012). 
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8.1 Introduction 
To evaluate the potential use of SesC as a vaccine target, we set out to make a monoclonal 
antibody against this protein. This monoclonal antibody may help us to find the best epitope 
of SesC for vaccine development. The most common epitope mapping approaches are the 
generation of consecutive, overlapping synthetic peptides (usually <15 aa) which cover the 
complete primary sequence of the protein antigen or using a bacterial surface display of 
antigen protein fragments. Both are usually followed by screening for antibody binding by 
ELISA and western blotting (Mirshahidi et al., 2009; Hudson, Uhlen, & Rockberg, 2012). 
As a future perspective, it would be interesting to use both methodologies to identify linear 
and conformational epitopes of this target. 
8.2 Materials and Methods 
To obtain monoclonal antibodies, we used the Hybridoma technology. A hybridoma is a cell 
that can be generated by fusing a spleen cell from an immunized animal with a Myeloma 
cell and that is capable of secreting permanently in culture, a monoclonal antibody specific 
to one epitope of the antigen.  This technique follows the steps summarised below (Figure 
8.1). 
8.2.1 Purification of recombinant protein 
Construction and purification of histidine-tagged fusion SesC proteins was done as 
explained (Chapter V); briefly, the recombinant extracellular domain of the SesC protein 
was expressed with an hexahistidine tag at its C terminus using the expression vector 
pET11c (Novagen, Madison, WI). Forward (ACGTGCTAGCGCAGATTCAGAAAGTACATC) and 
reverse (ATGCGGATCCTAGTGATGGTGATGGTGATGATCAGCTGTAGCTGTTCC) primers with 
incorporated flanking NheI and BamHI restriction sites (underlined) and a sequence coding 
for a C-terminal His6 tag (in italic and bold) were used. The sesC amplicons were cloned in 
pET11c and the resulting plasmids (pET11c-sesC) were transformed into E. coli BL21 
(DE3) (Hermans et al. 2006). The resulting plasmids were used for recombinant protein 
production. 
Recombinant protein expression was achieved as previously described (Hermans et al. 
2006). Briefly, after transformation, E. coli BL21 (DE3) was grown with shaking (250 rpm) 
at 37ºC in Luria-Bertani (LB) broth with 100 µg/ml ampicillin to an OD600 of 0.6-1.0. 
Expression was induced by addition of 1 mM IPTG for 2 h. After cooling on ice, cells were 
harvested by centrifugation (4000 rpm, 10 min at 4ºC) and resuspended in 5 ml imidazole 
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buffer (20 mM phosphate, 0.5 M NaCl, 10 mM imidazole) and frozen at -20ºC. Cells were 
first thawed on ice and then sonicated 3 times for 30 s. After centrifugation (30 min, 15000 
rpm at 4ºC) the supernatant was used for Ni+ affinity chromatography purification of the 
recombinant proteins with the HisTrap™ Kit (Amersham Pharmacia, Uppsala, Sweden). 
The columns were washed with 40 mM imidazole buffer and proteins were eluted with 300 
mM imidazole buffer. The purified recombinant protein was dialyzed against 10 mM 
HEPES buffer, pH 7.5, freeze dried, and stored at -20 °C.  
 
Figure 8.1. Stages of monoclonal antibody production, (van Ewijk 1985) . 
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8.2.2 Immunization 
Immunization is one of the most important steps. In this step, 50 µg recombinant protein (r-
SesC) were mixed well with complete Freund's adjuvant (CFA) in equal volume and 
injected intraperitoneally into each mouse (5 weeks Swiss mouse strain). Then after 10 days 
post injection, the mice were boosted with approximately the same dose of antigen mixed 
with incomplete Freund's adjuvant (IFA) (van Ewijk 1985).  
Seven days after the boost immunization, blood was taken and tested for a positive immune 
response against the respective antigen, by ELISA. Four weeks later, the mice were boosted 
by third intraperitoneal injections of 50 µg antigen in saline four days before cell fusion.	 
8.2.3 Hybridoma production 
One week before fusion, we expanded the SP2/0-Ag14 myeloma cell line (the fusion partner 
cell line). On the day of fusion, the boosted animals were sacrificed and the spleen was 
aseptically harvested and put into a petri dish containing RPMI-1640 medium (Sigma-
Aldrich). Under a laminar flow hood, as many spleens cells as possible were removed from 
the capsule. Cells were mixed very gently and transferred to 15 ml tube containing medium. 
The myeloma and spleen cells (Figure 8.2) were counted and adjusted to 1:10 ratio 
myeloma/spleen. The cells were centrifuged and washed with 10 ml of the medium without 
FBS and subsequently the two cell lines were mixed into one 50ml centrifuge tube and 
centrifuged 5 minutes at 300 g. The pellet was re-suspended with 1.2 ml of PEG very gently 
in a water bath. Then, first 1ml RPMI without FBS was added to the tube very gently over 1 
min. In succession, this step repeated with 2 ml, 4 ml, and 8 ml of serum free medium and 
kept in a water bath for 15 min. Afterwards, the cells were centrifuged for 5 min at 300 g, 
and very gently resuspended in 10 ml of RPMI containing 1% Ultroser G (Pall Ref. 15950-
017), 10% FBS (Genycell Ref. GCS0101-500) and antibiotics (100 U/mL Penicillin and 100 
µg/mL Streptomycin), followed by adding 190 ml of the same warm medium and was 
aliquoted 1 ml of the suspension into each well (8 x 24-well plates). 
24 h after fusion, 1 ml of the medium with HAT (Hypoxathine, Aminopterin, Thymidine) 
(Gibco Ref. 21060-017) was added and the plates were left in the incubator till colonies 
appeared after approximately 14 days (http://www.euromabnet.com/protocols/). 
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Figure 8.2. Live microscopy images of splenocytes, myeloma cells and hybridoma cells (40x 
magnification). 
8.2.4 Screening and Cloning  
Most wells may not contain the desired antibody or may contain nonproducing hybridomas. 
Screening is done to determine which wells contain hybridomas that secrete the desired 
specific antibody.   
To this purpose, first we checked and estimated the number of growing positive hybridomas 
using a microscope and performed ELISA. When cells in the 24-well plates were 25% to 
50% confluent, they were frozen and used for cloning by limiting dilution. 
We followed the cloning procedure to ensure that the desired hybridoma cell line produced 
is obtained from a single fused cell. The method that we used for cloning was that of 
limiting dilutions. This was done for all candidate cell lines. The candidates were re-cloned 
and ELISA was performed by taking 100 µl of the medium of each clone. This step was 
repeated and we got the best hybridomas cell line. 
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Figure 8.3. Schematic representation of the monoclonal antibodies production protocol used in this 
study, which contains all the steps such as immunization, hybridoma production, screening, cloning, 
expanding and freezing down hybridomas, and antibody validation required for the production of a 
high quality monoclonal antibodies (https://www.euromabnet.com/protocols/).  
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8.2.5 Antibody purification  
The antibody was purified using Protein G mag sepharose (GE Healthcare). First the 
supernatant of selected cells was mixed with 100 µl of Protein G mag sepharose in an 
Eppendorf tube, then incubated whilst rotating for 1 h. Subsequently, the Eppendorf tubes 
were placed in a magnetic rack, the unbound fraction was discarded and the bead-bound 
antibodies were extensively washed with 1x PBS. IgGs were eluted subsequently with 0.1 M 
glycine/HCl buffer at pH 2.7, and the eluted part was immediately neutralized with 1 M Tris 
buffer (pH 8.5). The total IgGs from the serum of the hyper-immunized mice (from the 
blood of mice that served as splenocyte donors and contained hyperimmune serum) was also 
purified as a control, and all purified IgG was stored at -20°C. Then 10 µlfrom each purified 
IgG were loaded on the SDS gel and stained. ELISA and Western blot were also performed 
with this IgG, as primary antibody, and HRP-mouse secondary antibody was always used to 
detect primary antibody attached to SesC protein. Then by pipetting 100 µl of TMB Reagent 
after sufficient color development, 100 µl of Stop Buffer added to each well and the plate 
were read in the absorbance of 450 nm. 
8.3 Results 
To generate MAs towards surface protein SesC, five Swiss mice were immunized with r-
SesC and after 14 days the ELISA results confirmed the successful immunization in all five 
mice. 
 Consecutive fusions were performed first for spleens of 2 mice and the resulting hybridoma 
colonies were screened for expression of antibodies against SesC, but no positive hybridoma 
colonies were observed. In the second attempt, 50 colonies out of 70 colonies were positive 
and the antibodies produced by the hybridoma colonies (Figure 8.4) were tested by Western 
blot (Figure 8.5). The best colonies were expanded and frozen. These MAs will be further 
characterized. 
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Figure 8.4. The Coomassie stained gel contains IgG purified by G mag sepharose. In order 
to evaluate expression levels of antibody, we loaded 10 µl of the purified IgG on the SDS gel. 
Numbers from 1 to 6 shows different IgG achieved from different cell lines. According to the 
known structure of IgG, the heavy chain (HC) and light chain (LC), are shown by arrows. 
 
 
	
Figure 8.5. Western blot analysis performed for rSesC by the MAs. The 68 kDa band contains 
SesC protein, and is detected by the IgG purified from two different hybridoma cell lines. 
	
	
8.4 Discussion 
To recognize the best epitope of SesC, we made monoclonal antibodies against this protein. 
Polyclonal antibodies are the antibodies of choice when we need to recognize multiple 
epitopes of the antigen while the monoclonal antibodies help to recognize one single 
epitope. In addition, every batch of monoclonal antibodies has no or very low variability.  
As explained in this chapter, we followed a standard monoclonal antibody protocol to find 
candidates for the epitope mapping of SesC. We obtained several hybridoma cell lines with 
SesC positive ELISA’s and Western blots and we got one specific band for SesC at 68 kDa. 
To confirm the specificity of antibodies further assays such as mass spectrometry and FACS 
should be done. 
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All the experiments that have been done with polyclonal antibody should be repeated for 
these monoclonal antibodies to see if the biofilm and the rate of infection in the infected 
mice are significantly reduced. 
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General Discussion 
 
S. epidermidis is a skin colonizer that apparently evolved as a non-pathogenic species. 
However, these last decades, nosocomial infections by these bacteria got more and more 
frequent, so they obtained much attention. 
Different factors in these bacteria help them to easily attach to the surface and also attaching 
to each other and make strong biofilms. It was shown that surface proteins have important 
roles in helping these bacteria to make biofilms (Foster et al. 2014).  
It was reported that polyclonal antibodies against surface protein SesC can significantly 
reduce the biofilm of S. epidermidis (Shahrooei et al. 2009). In the current study, we tried to 
explain how this protein could be involved in biofilm formation.  
To understand this, we first tried to find a sesC natural mutant in S. epidermidis, to check 
how absence of SesC, can affect the biofilm of these bacteria. To this purpose, 175 S. 
epidermidis isolates were collected from the patients in UZ Leuven hospital and 
identification of all was confirmed by MALDI-TOF/TOF mass spectrometry and all isolates 
were checked for the presence of sesC by a colony PCR assay. The results showed that sesC 
was present in all isolates. Then we checked another 263 CoNS and S. aureus for sesC, but 
the results showed that sesC is specific to S. epidermidis. 
 Knockout of a gene can help to learn about the function of a protein. We attempted to knock 
out the sesC gene in S. epidermidis, but in spite of sustained efforts, we were unsuccessful. 
We then used antisense RNA, and that also didn’t work. These results suggest that sesC is a 
conserved gene in S. epidermidis, and maybe it is also an essential gene.  
Subsequently, we used an alternative strategy, which was expressing SesC in S. aureus and 
we examined the changes in the biofilm formation. Since the mechanisms of biofilm 
formation in S. epidermidis and S. aureus are similar, we transformed S. aureus strains with 
different mechanisms of biofilm formation (proteinaceous or PIA-dependent), and examined 
the effects.  
It was shown before that different compounds and growing conditions affect the expression 
of genes and these in turn will affect the quality of biofilm and can even change the 
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phenotype of biofilm. Environmental factors such as sugar, salt, pH and other nutrients have 
been demonstrated to impact on biofilm formation (Pan et al. 2010). The presence of glucose 
or NaCl can influence biofilm production. NaCl represses proteinaceous biofilm by 
activation of the accessory gene regulator (agr) system, and stimulates PIA-dependent 
biofilm via activation of SigB that inhibits transcription of icaR, a regulator of icaADBC 
operon expression (McCarthy et al. 2015). Glucose induces biofilm by stimulation of sarA 
expression and interestingly by acidification of the culture media (Rode et al. 2007; Conen 
et al. 2008; O’Gara 2007). 
Expression of SesC in S. aureus BH1CC that normally expresses a protein-dependent 
biofilm in BHI medium containing glucose or NaCl, didn't show any differences in 
comparison to the wild-type strain or a strain transformed with a mock plasmid. However, 
transformants of S. aureus 8325-4 with sesC could not make biofilm in the presence of 
NaCl.  
Treating the biofilms of these transformant strains in the presence of glucose with sodium 
metaperiodate or proteinase K showed that expression of SesC caused switching of the PIA-
biofilm to a protein-dependent biofilm. This phenomenon also happened when S. aureus 
was overexpressing the surface protein SasG (Corrigan et al. 2007). These data show that 
some surface proteins have dominant roles in biofilm formation, even when there is 
expression of ica genes.  In another series of experiments, another S. epidermidis surface 
protein, sesK, was transformed into this S. aureus strain as a control. Antibodies against 
SesK did not affect the biofilm in S. epidermidis. Transformation of S. aureus 8325-4 with 
sesK didn’t affect the biofilm formation of this strain. 
Our dot-blot results for the expression of PIA in transformant strains with sesC compared to 
wild type showed that SesC didn’t have any effect on the expression of PIA. However, since 
in the presence of NaCl, we found a big reduction of biofilm amount, there should be a 
defect in the sorting of PIA to the surface in the presence of SesC. That may be due to an 
effect on  IcaC or IcaB, since they have important roles in transferring PIA to the surface. 
To confirm this, S. aureus 8325-4::ica, which is a non-biofilm forming strain, was 
transformed with sesC and we checked whether there were any changes in biofilm 
formation. SesC induced this non-biofilm forming strain to form a protein-dependent 
biofilm.  
To further answer the question if SesC can directly affect biofilm formation and if these 
changes are due to the presence of SesC on the surface, S. aureus strain 8325-4 with srtA 
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mutation was transformed with sesC, and interestingly SesC switched this biofilm forming 
strain to a non-biofilm forming strain. To be sure that in this strain SesC could not sort to the 
surface, we separated the soluble proteins from insoluble proteins. Since the membrane and 
cell wall anchored surface protein are in the insoluble fraction, our results confirmed that 
SesC is expressed but is mostly present in the soluble part and not in insoluble fraction. The 
switch of S. aureus 8325-4 srtA::tet (pCNsesC) to a non-biofilm forming strain suggests that 
the presence of SesC in the cytoplasm leads to PIA sorting defects. Complementation of the 
non-biofilm-forming S. aureus 8325-4 srtA::tet (pCNsesC) with srtA by means of 
transformation with pSRsrtA5 turned it to a proteinaceous biofilm-forming strain. These 
data confirm that transformation with sesC is sufficient to switch the mechanism of biofilm 
formation to a proteinaceous type biofilm on condition that SesC is sorted to its place on the 
surface. 
It was shown that some MRSA strains naturally show different characteristics to make 
biofilm in medium containing glucose or NaCl. This suggests that depending on 
environmental conditions, different expression of proteins can lead the strains to form 
different types of biofilm. For example, strain S. aureus S115 generates PIA but is a non-
biofilm-forming strain. This may be because of the existence of a defect in the export of PIA 
by IcaC or IcaB (Vergara-Irigaray et al. 2009). Similarly to the effect of FnAB on biofilm 
phenotype in S. aureus strain S132 and BH1CC, there is the possibility that the extracellular 
location of SesC changes the architecture of the cell wall to the extent that PIA can no 
longer link the cells. This hypothesis is consistent with the observed effect of biofilm 
dispersal agents on sesC- and ica-positive strains (Vergara-Irigaray et al. 2009). 
We also used a polyclonal antibody against SesC on the biofilms of strains transformed with 
sesC and compared this effect with the impact on the strain transformed with sesK and wild-
type biofilms. The results showed a significant reduction of biofilm but only in the strain in 
which SesC was expressed. 
It was also shown that active immunization with the recombinant SesC significantly 
decreases the S. epidermidis biofilm formation in a subcutaneously catheterized rat model	
(Shahrooei et al. 2012). 
In this study, we developed a jugular vein catheterized mouse model and we infected the 
mice with an S. epidermidis strain and checked the influence of polyclonal antibody against 
SesC. We observed a significant reduction of infection in the organs and catheter compared 
to the untreated mice. Following this, we infected the mice with S. aureus transformed with 
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SesC, SesK, and mock plasmid and treated them with this antibody. These results again 
proved the important role SesC can play in staphylococcal infection. 
To understand the effector function of this antibody, we performed different assays, such as 
neutralization and opsonophagocytosis assays, and the results suggest that this antibody has 
an opsonophagocytic killing. 
Although we have to be cautious in extrapolating conclusions based on data obtained in S. 
aureus to S. epidermidis, we suggest that SesC is a virulence factor associated with the early 
stages in S. epidermidis biofilm formation, such as adhesion and colonization. This way 
SesC may favor chronic, persistent infections on indwelling biomaterials. The biofilm 
formation abilities of S. epidermidis may be due in part to the presence of SesC and similar 
factors (Khodaparast et al. 2016b).  
 
Future perspective 
This study showed that SesC can be considered as a potential target for immunization 
against S. epidermidis infection. Further work should be directed to finding the best epitopes 
of SesC. To this end, more work has to be done, such as:  
• Constructing monoclonal antibodies against SesC that can be used for in vivo studies 
and that can reduce the rate of infection in the infected mice as well as the polyclonal 
antibody and using these monoclonal antibodies to find the most immunogenic 
epitope.  
• Investigating the mechanism of action of the antibodies; for example blocking of the 
targeted molecule functions, or modulation of signaling pathways. 
Since biofilm formation in S. epidermidis is a complicated process with many different 
factors involved, different targets for immunization may be present. The best candidate 
epitopes from the most important factors involved may be combined and used as an antigen 
to vaccinate against these bacteria. 
Considering our unsuccessful efforts to knock out SesC in these bacteria, we believe that 
sesC is an essential gene. To understand the role of SesC, we may have to study its role in a 
broader way instead of just focusing on the function in the biofilm formation.  
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